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Summary
Summary
Specific binding sites for atrial natriuretic peptide (ANP) secreted from the 
heart of several species have been identified in cultured PC 12 
phaeochromocytoma cells, a cell line derived from a tumour of the rat adrenal 
medulla.
The i^I-labelled ANP bound specifically to PC 12 cells with a dissociation
constant (K^) of 794 pM and a receptor density (B ^ ^ )  of 256 femtomole/mg
protein. Fiscus et al., (1987) demonstrated that ANP stimulated the 
accumulation and efflux of cGMP in cultured PC 12 cells. This observation 
lends strong support to the present study and suggests ANP acts via specific 
cell surface receptors to exert its second messenger action.
Binding of ^^^I-ANP (99-126) to a plasma membrane preparation from 
PC 12 cells increased with increasing protein concentration and remained 
linear up to 100 gg protein /100 \xl. The kinetics of ligand binding to the 
membrane suggested that ANP was degraded in studies performed at 31°C 
and 22°C but remained almost intact when experiments were carried out at 
0°C (on ice). These results were confirmed by HPLC which revealed that 
70%, 14% and 3.6 % of ANP remained intact after Ih incubation at 0°C, 
22°C and 37°C respectively. 90% of ANP incubated without the membrane 
remained intact after Ih at 0°C . Hormones unrelated to ANP such as A II, 
bradykinin and arginine-8-vasopressin did not compete for the binding sites; 
however, hormones related to ANP competed for the receptors with the 
following order of affinities: rat atrial peptide fragment 13-28 aa > r-ANP (28 
aa) > h-ANP ( 28 aa) > r-ANP (8-33 aa) rat atrial peptide fragment
(l-llaa)>atriopeptin I.
A II binding sites were not expressed either in normal PCI2 cells or 
NGF-treated cells (neuron-like). A catecholamine radio-enzymatic assay was 
used to show that dopamine but not adrenaline or noradrenaline was secreted 
from PC 12 cells. This result is in agreement with those of Nagatsu et aL, 
(1987) and Ahnert-Hilger and Gratzel (1987). One of the techniques used 
for looking at dopamine release from PC 12 cells was to incubate them with 
^H-dopamine and then expose them to different concentrations of potassium. 
The release was higher at 37mM and even higher at 70mM compared 
with cells incubated with 5mM K+. Since ANP has specific receptors on 
PCI2 cells the effect of ANP on neurotransmitter release were investigsted. 
PC 12 cells were exposed to 5 and 70mM in the presence of ANP at final 
concentration of lO'^M. ANP had no statistically significant effect on the 
release of dopamine from PC 12 cells.
PCI2 cells were shown to contain ANP by measuring ANP released either 
under perfusion conditions or after homogenization. The results from 
homogenized cells for ANP release were 420 pg/ml for non-trypsinized cells 
and 284 pg/ml for trypsinized cells.
The supernatant obtained from homogenized PC 12 cells was used in another 
radio-immunoassay to determine renin activity. PC 12 cells did contain 
renin, since angiotensin I was generated after incubating samples with 
angiotensinogen (renin-substrate) for 5h at 37° C.
The presence of these three major blood pressure controllers (dopamine, 
ANP and renin ) within PC 12 cells, shows clearly that these tumour cells 
provide an excellent model system for investigating biosynthesis, maturation
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and secretion of atrial peptides (Nguyen et aL, 1988), as well as the 
physiological role of the co-secretion of neuropeptides and catecholamines in 
the nervous system (differentiated PC 12 cells).
In conclusion, PC12 cells represent an extremely useful model system in 
investigating many aspects of blood pressure regulation.
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Introduction
1. Introduction
The regulation of blood pressure in mammals is under the control of both 
nervous and endocrine systems. Expansion of extracellular volume, 
activation of the sympathetic nervous system, or increased activity of the 
renin-angiotensin system will often result in hypertension (Landsberg and 
Youngjl981). Blood pressure is regulated in two main ways;
1.1 Nervous regulation
The sympathetic nervous system affects the heart, veins, kidneys and 
arterioles (Landsberg and Youngs 1981). The hypothalamus is well 
established as a major organ of cardiovascular control. When various areas 
of the hypothalamus are stimulated an increase or decrease in heart rate and 
modulation of the baroreceptor reflex is observed ( Brody et aL, 1983).
1.2 Hormonal regulation
1.2-1 Angiotensin 11
One of the main systems responsible for the maintenance of blood pressure is 
the renin-angiotensin system. Juxtaglomerular cells in the kidney synthesize 
and release renin, an enzyme which cleaves renin substrate 
(angiotensinogen), which is synthesized by the liver, to form angiotensin I. 
Angiotensin I is cleaved by angiotensin converting enzyme to form an 
octapeptide angiotensin U (A II) (Fig. 1). The conversion of angiotensin I to 
angiotensin II takes place in the vascular endothelium, particularly in the 
pulmonary circulation (Vane et aL, 1967).
A n  increases cardiac output through a positive inotropic effect due to its 
action on P2-adrenergic receptors (Freer et aL, 1976) and elevates blood 
pressure by having a direct vasoconstrictor effect on blood vessels (Bohr and 
Uchida,1967). A II also affects the brain, by stimulating thirst (Epstein et
Fig.l . The sequence of angiotensin II
al., 1970) and the release of vasopressin ( Bonjour and Malvin,1970) from 
the posterior lobe of the hypothalamus gland. The effect of A n  on the kidney 
is to decrease renal blood flow and glomerular filtration rate (Navar and 
Langford,1974).
Angiotensin II controls the secretion of aldosterone which is released from 
the zona glomerulosa of the adrenal cortex (Fraser et al., 1981). When high 
levels of A II are infused into dogs an increase in circulating levels of 
aldosterone is observed (Fraser et al., 1981). Hyperactivity of the 
renin-angiotensin system due to high circulating levels of angiotensin n  or 
due to the presence of high levels of renin, from renin-secreting tumours of 
the kidney, usually results in hyperaldosteronism ( that is an excess of 
aldosterone in the circulation). Hyperaldosteronism leads to an increase in 
reabsorption of Na+, Ch and water and to decreased reabsorption of K+- 
Fluid and sodium retention in turn, cause an expansion of blood volume 
followed by high blood pressure (Keeton and Gould^l986).
1.2-2 Catecholamines
The adrenal medulla, which is the inner part of the adrenal gland, secretes 
and releases the catecholamines, adrenaline and noradrenaline into the blood 
stream. These hormones, which are released under stress conditions, 
stimulate the liver to supply more glucose to the blood and increase heart rate 
which in turn elevates blood pressure (Fig. 2).
1.2-3 Thyroid hormones
Thyroid hormones, thyroxin-T4- and triiodothyronine-T3-, are secreted into 
the blood stream from the thyroid gland. Hypothyrodism ( low circulating 
thyroid hormone ) is associated with impaired renal water excretion 
(Derubertis et al., 1971), vasoconstriction and an increased peripheral 
vascular resistance (Davies et al., 1952); however hyperthyrodism (high
F ig .l. Stress and secretion of catecholamines.
The brain responds to stress by sending impulses to the adrenal glands 
(located above the kidney ) and to sympathetic neurons through nerves in 
the spinal cord. The adrenal gland secretes adrenaline, noradrenaline and 
other substances into the bloodstream to act on a number of target organs. 
Sympatlietic neives however discharge noradrenahne locally.
(After Carmichael and Winkler, 1985).
Fig.l. Stress and secretion of catecholamines
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circulating thyroid hormone) is associated with natriuresis and vasodilatation 
(EqW et aL, 1982). Landenson gf a/., (1988) has demonstrated elevated 
levels of circulating atrial natriuretic peptide (ANP), a hormone involved in 
blood pressure regulation, in rats with hyperthyroidism compared with 
hypothyrodism. This is consistent with the above findings.
1.2-4 Prostaglandins
Under various stimuli, such as nerve stimulation and mechanical 
disturbances, prostaglandins can be synthesized and released from most 
tissues. They owe their name to the hydrocarbon skeleton prostane and are 
derivatives of arachidonic acid. Because of their occurence in the kidney and 
tendency to lower blood pressure, they might function as antihypertensive 
substances (Passmore and Robson, 1980).
1.2-5 Pancreatic hormones
Beta and alpha cells in the islets of Langerhans in the pancreas secrete insulin 
and glucagon into the bloodstream. These hormones may influence sodium 
balance thus modifying blood pressure indirectly (Kolanowski^ 1981 ). 
Insulin has been shown to stimulate growth in cultured vascular smooth 
muscle cells and this may be important in the development of hypertension in 
diabetic patients (Kaiser,1985).
1.2-6 The atrial natriuretic peptides
The atrial natriuretic family of peptides are known to be potent vasorelaxants. 
They oppose the effect of vasoconstrictors such as adrenaline, noradrenaline 
and angiotensin II. It is believed that atrial natriuretic peptides have an 
important role in the regulation of fluid volume and blood pressure and this 
will be discussed in more depth in section 4.
1.3 Phaeochromocytoma and hypertension
Phaeochromocytomas are tumours of chromaffin cells of the adrenal medulla. 
Hypertension caused by a phaeochromocytoma is due to an excess of 
circulating catecholamines ( adrenaline and noradrenaline ) secreted by the 
tumour. It is a relatively rare condition as only 0.1% of patients with 
diastolic hypertension have a phaeochromocytoma (Sleight and Freis,1982). 
It ends in death if untreated but normally it is cured by surgery. 
Phaeochromocytoma will be discussed in more detail in section 3.
2. The adrenal medulla
2.1 The adrenal gland
The adrenal gland is a double gland located above the kidney. It is composed 
of an inner part known as the medulla and an outer part known as the cortex. 
The adrenal cortex is organized into 3 concentric zones (Fig. 3) which secrete 
a large number of steroid hormones derived from cholesterol (Keeton and 
Gould, 1986).
The outer zona glomerulosa secretes mineralocorticoids. These hormones 
regulate salt and water balance. The zona fasciculata secretes glucocorticoids. 
These hormones are involved in the regulation of carbohydrate and protein 
metabolism. Finally the innermost zona reticularis secretes sex hormones 
which are very similar chemically and functionally to the sex hormones 
produced by the gonads (Keeton and Gould, 1986).
2.2 Definition and function of the adrenal medulla
The adrenal medulla is viewed as sympathetic ganglia, which are innervated 
by preganglionic cholinergic fibres (Passmore and Robson, 1980). 
Chromaffin cells form the adrenal medulla; their name is derived from the 
observation that adrenaline released from the adrenal medulla reacts with 
chromium salt to produce a yellowish brown colour (Carmichael and 
Winkler, 1985). These cells extend axon-like processes in culture suggest 
the close relationship of these cells with neurons (Carmichael and Winkler, 
1985). Chromaffin cells secrete the catecholamines adrenaline, 
noradrenaline and, to a limited extent, dopamine into the bloodstream. 
Adrenaline and noradrenaline are found in many animals; dopamine is 
abundant in insects (Passmore and Robson, 1980). Plants, fruit and
Fig.3. Structure of the adrenal gland (cortex and medulla). 
(After Jeffcoate, 1986)
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vegetables also contain catecholamines. Because these catecholamines are not 
absorbed from the gastro-intestinal tract, they do not produce any effect on 
the organism (Passmore and Robson, 1980).
2.3 Catecholamines and their concentrations in the bloodstream
In normal human peripheral blood the concentrations of catecholamines are 
extremely low making their accurate measurement difficult. Their ranges 
are for noradrenaline: 1.2—2.4 nM, dopamine 0.6—1.3 nM and adrenaline 
about 0.5 nM (Passmore and Robson, 1980).
2.4 Adrenergic receptors and catecholamine effects 
Adrenaline, noradrenaline and dopamine function both as hormones and 
neurotransmitters. Usually adrenaline acts as an endocrine hormone but it is 
also a neurotransmitter for some neurones. Noradrenaline, however, usually 
acts as a neurotransmitter (Darnell et al., 1986), Adrenaline and noradrenaline 
are widely distributed throughout the body and transmit their message 
through specific receptors on target organs. There are 3 major types of 
receptors for catecholamines: a-adrenergic, p-adrenergic and dopamine 
receptors. They can be distinguished by their ligand specificity, their 
biochemical responses and their responses to specific blockers agonists and 
antagonists (Levitzki, 1980). Binding of adrenaline or noradrenaline to 
P-adrenergic receptors on hepatic cells (liver), adipose cells and heart muscle 
causes glycogenolysis, lipolysis and increases the rate of contraction 
respectively, thus supplying more oxygen, fatty acids and glucose to fuel 
the tissues (Damell et al., 1986). The binding of adrenaline and noradrenaline 
to p-adrenergic receptors is associated with inceased levels of cAMP as a 
signal transducer (Levitzki, 1980). Binding of a-agonists to a-adrenergic 
receptors is associated with constriction of arteries which reduces the blood
supply to peripheral organs. Receptor binding is coupled to an influx of 
Ca++, which acts as a second messenger, coupling signal and response 
(Levitzki,1980 ). A separate class of a-adrenergic receptors is coupled to the 
enzyme adenylate cyclase in the central nervous system. This discovery was 
based on studies showing that a-adrenergic blockers inhibited the formation 
of cAMP ( Levitzki, 1980 ). Physiologically a and p-adrenergic receptors 
oppose each other in target cells (Table 1).
2,5 Biosynthesis of catecholamines in the adrenal medulla
Catecholamines are synthesized in the adrenal medulla, the brain and 
sympathetic nerve endings (Musacchio et al., 1963) and in cells of neural 
crest origin throughout the body ( Melmon,1974 ). Tyrosine is the primary 
substrate for catecholamine synthesis in mammals and it is derived mainly 
from the diet (Fig.4). The main rate-limiting enzyme involved in the 
synthesis of catecholamines is tyrosine hydroxylase, which is found only 
within catecholamine-producing cells. This enzyme convert 1-tyrosine to 
1-dihydroxyphenylalanine (DOPA). DOPA is rapidly converted to 
l-dihydroxyphenylethanolamine (dopamine) by aromatic 1-amino acid 
decarboxylase, an enzyme which is found in many tissues including the 
cytoplasm of chromaffin cells (Manger and Gifford, 1977). Dopamine is then 
taken up into cytoplasmic vesicles by an ATP-dependent mechanism. These 
vesicles contain dopamine p-hydroxylase (DBH), which hydroxylates 
dopamine to form noradrenaline when ascorbic acid, oxygen and fumaric 
acid are present as cofactors. Some of the chromaffin cells can convert 
1-noradrenaline to 1-adrenaline using phenylethanolamine-N-methyl 
transferase (PNMT), an enzyme found only in the adrenal medulla (except 
for minute quantities in heart and brain). The activity of PNMT is dependent
Table 1. Some physiological actions of adrenergic receptors . 
( After Levitzki, 1980).
System or tissue Action Receptor
Heart Increased force of contraction 
increased rate
Blood vessels Constriction a
Dilation P2
Respiratory system, tracheal 
and bronchial smooth muscle
Relaxation P2
Iris (radial muscle), Pupil dilated a
smooth muscle, uterus. contraction a
Spleen Relaxation P2
Contraction a
Bladder Contraction a
Relaxation P2
Skeletal muscle Changes in twitch tension P2
Increased release of 
acetylcholine
a
Increased glycogenolysis P2
Adipose tissue Increased lipolysis Pi
Parotid gland Enzyme secretion p
Water and K+ secretion a
Fig.4. Biosynthesis of catecholamines 
(Passmore and Robson 1980)
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on glucocorticoids synthesized from the adjacent adrenal cortex (Manger and 
Gifford, 1977), Noradrenaline has to move to the cytoplasm, where PNMT 
is located, for the méthylation reaction. Adrenaline is then transported back 
into vesicle for storage ( Manger and Gifford, 1977 ).
2.6 Storage and release of catecholamines
Chromaffin vesicles store not only catecholamines but also ATP and a diverse 
mixture of proteins. The most abundant components are acidic proteins called 
chromogranins. Neuropeptides of various sizes are also stored in the adrenal 
medulla (Carmichael and Winkler, 1985). After their synthesis and storage, 
catecholamines are released by stimulation with acetylcholine. The 
cholinergic fibres of the splanchnic nerves make cholinergic synapses on the 
chromaffin cell membrane, opening gates , which, by plasma membrane 
calcium channels, trigger the release of hormones by a mechanism known as 
stimulus-secretion-coupling. Chromogranins, dopamine p-hydroxylase and 
some other constituents of the vesicle are released along with the 
catecholamines (Passmore and Robson, 1980). Release of catecholamines are 
also stimulated by histamine, 5-HT, bradykinin and high concentrations of 
potassium. Calcium is always required for catecholamine release (Passmore 
and Robson, 1980). Dihydropyridines such as nitrendipine (a calcium 
channel antagonist ) block the release of catecholamines from adrenal 
chromaffin cell; release is enhanced by Bay K8644 (calcium channel agonist) 
(Kongsamut and Miller, 1986). Adrenaline and noradrenaline are released 
from the adrenal medulla as a result of insulin hypoglycemia. Hillarp and 
Hokfelt, (1953) suggested that there are two chromaffin cell populations. 
Hillarp et a i, (1954) have shown that adrenaline and noradrenaline are 
formed in two different cell types and released independently. Substances
8
such as glucagon (Scian et al.j 1960), nicotine, polocarpine (Dale et al., 
1912) and angiotensin (Feldberg et a/., 1964) stimulate catecholamine 
secretion from chromaffin cells by depolarizing cells to allow the entry of 
Ca+t K+, Na+, Ch and Mg++ are not necessary for catecholamine release 
(Manger and Gifford, 1977),
2.7 Inactivation of catecholamines
After their release into the bloodstream catecholamines are inactivated very 
rapidly. The enzymes involved in the degradation of catecholamines and the 
pathway followed in the inactivation are the same as in phaeochromocytoma 
PCI2 cells and this will be discussed in section 3.
2.8 Catecholamines as neurotransmitters
Adrenaline, noradrenaline and dopamine are the three main members of the 
catecholamine family. Each these has different and characteristic 
physiological functions, pharmacological actions, sites of production and 
pathways of metabolism (Passmore and Robson, 1980). They function as 
both hormones and neurotransmitters. Noradrenaline plays a major role at 
synapses with smooth muscle cells, and is responsible for the classic "fight 
or flight" reaction. It is also found at synapses within the central nervous 
system. When p-receptors are activated at p-adrenergic synapses, adenylate 
cyclase is activated whereas «-receptor activity involves changes in ion 
permeability where the first event is the influx of Ca++ (Levitzki^ 1980). 
Another class of a-receptor was found to be coupled to the enzyme adenylate 
cyclase ( Levitzki,1980).
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3. Phaeochromocytoma
Phaeochromocytoma are tumours of chromaffin cells. About 90% occur in 
the adrenal medulla, 2% in the chest and 0.1% in the neck (Sleight and 
Freis, 1982). They are composed of phaeochromocytes which are arranged 
in cords or in small or large alveolar patterns ( Page at aL, 1986). 
Phaeochromocytoma are sometimes located in the abdomen and the organ of 
Zuckerkandl, Histologically phaeochromocytoma are usually benign but 
physiologically they are malignant because they secrete catecholamines. In 
90% of cases a phaeochromocytoma is curable, but it is fatal if left untreated 
(Manger and Gifford, 1977). Phaeochromocytoma releasing dopa or 
dopamine are more likely to be malignant ( MacMillan, 1956).
3.1 Isolation of the cell line PC 12 from a rat phaeochromocyto­
ma and effects of nerve growth factor
The clonal cell line PC12, isolated by Greene and Tischler, (1976) has been 
established from a transplantable rat adrenal phaeochromocytoma. Adrenal 
medullary cells in vivo (Aloe and Levi-Montalcini, 1979) and PC 12 
phaeochromocytoma cells in vivo differentiate after exposure to nerve growth 
factor. They stop dividing, produce elongated neurite like processes, 
develop presynaptic terminals containing neurotransmitters and develop first 
calcium and then sodium action potentials (Dichter et al., 1977 ). After 
removal of NGF, the processes degenerate within 24h and cells revert to 
their original phenotype ( Greene and Tischler, 1976). The level of 
catecholamine release is not altered in PC12 cells grown in the presence of 
NGF when expressed on a per cell basis but does result in a 4 to 6 fold 
decrease in levels when expressed on a per mg of protein basis ( Greene and 
Tischler, 1976). Another clonal cell line from rat phaeochromocytoma was
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established by Goodman et al., (1979) in which NGF could induce tyrosine 
hydroxylase, the enzyme responsible for converting tyrosine to dopa. This 
was done by culturing uncloned cells from a rat phaeochromocytoma in 
tyrosine free-medium containing NGF. PC-G2 was the clone isolated in this 
fashion and responded to NGF by becoming neural-like (1-lOjag NGF/ml ) 
with an induction of tyrosine hydroxylase. PCI2 cells have been fused using 
polyethylene glycol to produce cells up to 300 p,m in diameter in order to 
perform electrophysiological studies. Without this treatment the cells would 
be damaged by penetration of microelectrodes due to their size (10-20p,m in 
diameter) (O'Lague and Huttner, 1980). Nerve growth factor is a protein 
known to stimulate neurite outgrowth from sympathetic neurones. It is 
required for the development and maintenance of these cells (Dichter et al., 
1977). PC12 cells respond to NGF by stopping cell division, extending 
processes and developing neuronal properties and causing changes in the 
apparent rate of synthesis of cytoplasmic and nuclear proteins (Tiercy and 
Shooter, 1986). In addition acidic fibroblast growth factor and basic 
fibroblast growth factor can be used to induce neurite outgrowth from 
phaeochromocytoma. The binding of basic fibroblast growth factor to the 
receptors is completely blocked by heparin (Neufeld et al., 1987).
PCI2 cells are very useful for physiological studies as well as as a model 
for cell-cell interactions. In the presence of NGF, PCI2 cells resemble 
neurons and synthesize, store and release acetylcholine (Greene and Rein, 
1977). PC 12 cells become sensitive to acetylcholine when differentiated with 
NGF. It would be of interest to investigate if PC 12 cells formed synapses 
with several target cells or with each other (Dichter et al., 1977). PC12 cells 
express action potential mechanisms for Na+, Ca++, K+ conductance and 
other K+ conductance mechanisms (O'Lague and Huttner, 1980). PC12
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cells, whether they are treated with NGF or not, are like normal chromaffin 
cells and sympathetic neurones in that they can generate action potentials 
(Biales et al., 1976). Since NGF plays the major role in promoting the 
maturation prossess of neuroblasts into neurones, and promoting the 
differentiation processes of phaeochromocytoma into neuron-like cells, PC 12 
cells could be a unique model system for studying the development of 
neuroblasts into mature neurons. Furthermore they could be useful for 
studies of the development of electrical excitability. Because NGF-treated 
PC 12 cells are sensitive to acetylcholine, they may respond to cholinergic 
fibers (Dichter et al, 1977).
3.2 Similarities between normal chromaffin cells and PC12 cells
PC 12 cells share several characteristics with adrenal medullary chromaffin 
cells.
a) The adrenal chromaffin cells and PC 12 cells are derived from the 
sympathetic nervous system originating from the neural crest (Carmichael 
and Winkler, 1985).
b) The normal chromaffin cells and PC 12 cells secrete catecholamine 
(Kongsamut and Miller, 1986).
c) Exocytosis is a common way of releasing catecholamines in both cells 
(Manger and Gifford, 1977).
d) The various enzymes necessary for catecholamine synthesis and 
inactivation are present in both cells (Manger and Gifford, 1977).
3.3 Differences between normal chromaffin cells and phaeochro­
mocytoma
Although these two different type of cells have many similarities, they still 
different in many other characteristics.
a) The adrenal medulla is innervated by the splanchnic nerve so that
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acetylcholine release, which is the result of activation of this nerve, induces the 
release of catecholamines from chromaffin cells. In contrast, there is no 
evidence showing that phaeochromocytoma is innervated (Cousins and Rubin, 
1974). The mechanism of cell stimulation is still not clear.
b) The granules in the adrenal meduUa contain a high concentration of ATP 
while some phaeochromocytoma contain low concentrations of this compound 
(Winkler and Smith, 1968)
c) Activation of the sympathetic nervous system during hypoglycemia 
results in the release of catecholamines from the adrenal medulla into the 
circulation but not from phaeochromocytoma (Cantu et ai, 1968).
d) The turnover of catecholamines in phaeochromocytoma is much faster 
than in normal chromaffin cell. This might explain the continuous release of 
these substances from phaeochromocytoma (Winkler and Smith, 1972).
e) The activity of nerves stimulating adrenal medulla cells controls the 
secretion rate of catecholamines but with phaeochromocytoma, the rate of 
release depends on the rate of synthesis (Winkler and Smith, 1968).
f) The mean size of granules in normal chromaffin cells is 170nm, whereas 
the mean size of granules in phaeochromocytoma cells is greater than 270nm 
(Victor gf a/., 1982).
g) Electron microscopy studies have shown the presence of light and dark 
cells in phaeochromocytoma, while in normal chromaffin cells only the dark cells 
were present (Tannen-Baum, 1975).
h) Winkler and Smith, (1968) suggested that the release of catecholamines 
from phaeochromocytoma was due to bypass of storage sites and diffusion of 
catecholamines out of the cell (Winkler and Smith, 1972). The granule's 
membrane could be destroyed by lysosomes that allow the release of 
catecholamines from phaeochromocytoma (Winkler and Smith, 1968).
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i) Phaeochromocytoma preloaded with ^H-dopamine and then 
permeabilized with Staphylococcal alpha-toxin release ^H-dopamine in the 
presence of Ca++. In contrast, normal chromaffin cells require an Mg-ATP for 
this release (Ahnert-Hilger and Gratzl, 1987).
3.4 Biosynthesis and release of catecholamines from PC12 cells
PC 12 cells have the enzymes necessary for catecholamine biosynthesis. The 
amount of catecholamines synthesized by PCI2 cells is greater than in the 
adrenal medulla. PC 12 cells secrete a combination of catecholamines and their 
metabolites and occasionally their precursors (Lightman, 1979). A lack of 
ordinary control mechanisms regulating synthesis or release of adrenaline or its 
precursors could help explain the unusual secretion rates and it has been 
demonstrated that tyrosine hydroxylase does not seem to be inhibited by the 
normal concentrations of noradrenaline in the cell. The enzyme could be 
unusual in having a different for its substrate or the amines could be held in 
compartments after their formation thus not allowing feedback inhibition of the 
normal enzyme. In addition, the tumour's metabolites have been shown to 
prevent the ordinary feedback inhibition of tyrosine hydroxylase by 
noradrenaline (Melmon, 1974). The release of transmitter substances from 
PC 12 cells increases under depolarizing conditions (Shalaby et al., 1984 ).
PC 12 cells are extremely sensitive to dihydropyridines as are normal 
chromaffin cells, but once they are differentiated (neuron-like) the release 
becomes predominantly insensitive to dihydropyridines. The release of 
^H-noradrenaline from preloaded, differentiated PC 12 cells was slightly 
enhanced by BAY K8644, and very poorly inhibited by nitrendipine even at 
high concentrations (Ogura and Takahachi, 1984). The release of adrenaline 
from differentiated PC 12 cells is less than in undifferentiated ones upon 
depolarization by 70mM K+ (12.2±0.22% undifferentiated cf 8.88+0.20%
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differentiated). Cells can be permeabilized by high-voltage discharge ( Baker 
and Knight, 1978), by saponins ( Dunn and Holz, 1983), or by alpha-toxin 
from Staphylococcus aureus.
3.5 Inactivation of catecholamines in PC12 cells
Catecholamines, taken up by either neuronal cells or extraneuronal cells like 
smooth muscle cells, are degraded very quickly inside the cell. The two main 
enzymes involved in the degradation of catecholamines are: MAO (monoamine 
oxidase) and COMT (catechol-O-methyl transferase). The major role of MAO is 
in the metabolism of tissue stores of catecholamines and in the further 
metabolism of O-methylated amines. COMT is widely distributed and present in 
almost all tissues in association with the methyl donor-S-adenosyl methionine. It 
is the major route of degradation of intravenously administred catecholamines 
(Manger and Gifford, 1977). Adrenaline can be deaminated by monoamine 
oxidase (MAO) plus aldehyde dehydrogenase in mitochondria to form unstable 
aldehydes which are then oxidized to an acid 3,4 dihydroxy mandelic acid 
(DHMA). Secondly, noradrenaline can be reduced to an alcohol, 
dihydroxyphenylglycol (DHPG). The second way occurs mainly in the rat 
whereas oxidation takes place in man. Catechol-O-methyl transferase ( COMT) 
converts noradrenaline released into the circulation to normetanorphine ( Manger 
and Gifford, 1977)
3.6 PCI2 responses
Many studies have been carried out on the response of phaeochromocytoma 
PC 12 cells to both inhibitors and stimulators. Dopamine release by high K+ 
concentrations ( 50mM ) from PC 12 cells was inhibited by a specific inhibitor 
of myosin light chain kinase (ML-9) (Nagatsu et al., 1987). In response to 
stimulation by bradykinin, angiotensin II and carbachol, PC 12 cells accumulate 
inositol phosphates (mono, bis and triphosphate) (Van Calker et al., 1987).
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Exposing PC 12 cells to nicotine (lO'^M) result in the release of adrenorphin 
along with catecholamines (Yanase et al., 1987). It is believed that PC12 cells 
contain high amounts of guanylate cyclase, which is a proposed second 
messenger of ANP. Atriopeptin I, atriopeptinll, atriopeptin III and human 
ANP stimulate cyclic 3', 5' guanosine mono-phosphate (cGMP) accumulation 
in PC12 cells ( Fiscus et al., 1987 ).
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4. Atrial Natriuretic Peptide
Mammalian atrial cardiocytes contain secretory granules which release atrial 
natriuretic peptide (ANP) into the bloodstream ( De Bold et al., 1981). 
However, in non-mammalian vertebrates, atrial and ventricular cardiocytes 
are involved in this secretion (Yunge et al., 1980). ANP is localised in the 
granules of cardiocytes and is released into the blood stream as a result of 
intravascular or extracellular (Lang et al., 1985) fluid volume expansion 
whereupon it exerts diverse cardiovascular, renal and endocrine effects. It 
may therefore be considered as a true circulatory hormone (Hirata et al., 
1985).
ANP is secreted at high levels in different conditions such as congestive 
heart failure, chronic renal failure and atrial distention through a mechanism 
called stretch-secretion coupling (Tiippodo, 1987). The evidence that ANP is 
secreted from the heart is the high concentrations of this peptide found in 
coronary sinus blood and low concentrations in peripheral organs (Sugawara 
et al., 1985). ANP is also secreted from atrial myocytes in culture (Gibson et 
al., 1987).
4.1 Isolation and sequence
ANP is synthesized as a 151 ( 152 in the rat ) amino acid residue precursor, 
prepro ANP. The first 25 amino acid (26 amino acid for rat) from the 
N-terminal end constitute a "signal peptide" which is presumably used in 
ribosomal processing of the peptide, this is removed before storage as a 126 
amino acid chain in granules in atrial cells (Genest, 1986). At the time of 
release the active 28 amino acid moiety is removed. The nomenclature of 
atrial peptide is not uniform. In 1987 a joint committee of the international 
society of hypertension, the world Organisation and the American Heart
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Association (Dzau et al., 1987) recommended that peptides should be named 
from the N-terminal end of the precursor pro ANP eg: rat ANP becomes ANP 
(99-126). There is great homology between species such that rat ANP differs 
only by the substitution of isoleucine for methionine at position 110. Smaller 
forms of rat ANP have been identified but all those with physiological 
activity contain a cysteine-cysteine disulphide bridge (cys 105-cysl21). The 
location of the ANP gene has been identified on the distal short arm of 
chromosome 1 in man, and on chromosome 4 in mice. ANP cDNA was 
cloned by Yangfeng et al., (1985). Recent studies have reported the 
presence of a specific gene in the brain (rat) encoding ANP-like related 
peptides. The fact that highly specific receptors for ANP have been identified 
in the brain (Table 4) and the recent studies about ANP gene transcript in the 
brain are strong evidence for the existence of an ANP system within the brain 
(Quirion, 1988). ANP (99 - 126 ) has recently been detected together 
with its precursor (Asn 1-Tyr 126) within bovine chromaffin granules (Ong 
et al., 1987; Flemminger et dz/., 1983). They confirmed the maturation 
process of atrial peptides in the adrenal medulla. Exposure of normal 
chromaffin cells to nicotine (lOpM) or KCl (56mM) induced an increase over 
the basal secretory level of immunoreactive ANP (from 27 ±12 up to 186+52 
femtomole f l x lQ l  cells ) and ( from 27+ 12 up to 180+53 
femtomole/2x 10^ cells) respectively (Nguyen et al., 1988). ANP was 
isolated, synthesized and sequenced by Seidah et al., in 1984 ( Fig.5).
4.2 Circulating levels of ANP
Much variation still exists among laboratories but the majority of studies show 
mean values for basal plasma ANP of healthy volunteers in the range of 
(10-60pg/ml) (Trippodo, 1987). ANP levels vary together with molecular 
forms of ANP according to age and cardiac condition ( Miyata et al..
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1985). In rats the plasma concentration of ANP is between 20-40 pM 
(60-120pg/ml). High concentrations of ANP in plasma, ranging from 
lOOpg/ml to 450pg/ml according to age and blood pressure, were observed in 
hypertensive rats. ANP levels increased from 117pg/ml to 238pg/ml during 
the development of salt induced hypertension in Dahl salt-sensitive rats 
(Tanaka and Inagami, 1986). Similarly high levels of plasma ANP were 
found in patients with severe congestive heart failure by Schiffrin et a l , 
(1986) and renal failure (Rascher et al., 1985). Plasma ANP levels are also 
elevated by infusing intravenously with isotonic fluid (Yamaji e? tz/., 1985).
4.3 The effects of ANP
4,3-1 On the kidney
It is well established that the kidney is the major site of ANP action (Espiner 
et al. 1986) (Table 2). Bolus injections of larger doses cause a rapid, 
massive and short diuresis and natriuresis within the kidney of dogs (Maack 
et al., 1984). Glomerular filtration rate (GFR) is increased together with 
filtration fraction in rats and man after intravenous injections of ANP. In 
addition, urine volume and sodium excretion is elevated (Genest, 1986). 
More recently low dose infusions of ANP have shown similar effects on 
sodium, calcium and magnesium excretion without increases in GFR or a 
diuretic response (Richards et al., 1988).
Maack et al., (1988) have shown that in rat kidney more than 95% of ANP 
receptors are biologically silent, in that ANP binding occurs without a 
functional response or cyclic GMP generation and these receptors were 
termed as "clearance receptors". Thus the kidney itself may profoundly 
unfluence the clearance, therefore the circulating plasma concentrations of 
ANP. Atrial but not ventricular extracts from mammalian species showed a 
natriuretic and diuretic activity, whereas in frog both atrial and ventricular
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Table 2: Summary of ANP effects and its main sites of action in 
the human body.
Effect Site of action Source
Direct blood pressure 
reducer
vessels and arteries Sagnella et al, 1985
Stimulates the cotransport 
ofNa+, Cl-and K+
vascular smooth 
muscle cells
Owen et al., 1987
Rapid, massive & short 
diuresis & natriuresis
Kidney De Bold et al.,19^1
Inhibition of renin 
secretion
Kidney Burnett et al., 1984
Increase circulating levels 
and urinary excretion of 
cGMP
Kidney Gerz&r et al., 1985
Increase cGMP Aortic tissues 
Adrenal gland 
Kidney
Avian epiphyseal 
growth plate chond- 
-rogenitor cells
PC 12 cells 
Astrocytoma cells
Hirata era/., 1985 
Hinko et al., 1987 
Takeda era/., 1986 
Pines &Hurwitz, 
1988
Fiscus era/., 1987 
Lyall era/., 1988
Plasma aldosterone 
and A&NA concen- 
-tration depressed
Blood Richards et al., 1985
Induces release of 
arginine-8-vasopressin
Posterior lobe of the Januszewicz et al.,
hypophysis 1986
Inhibition of cortisol Bovine adrenal cortex Chattier & Schiffrin, 
secretion 1987.
extracts showed both these actions. Ventricular but not atrial extracts showed 
diuresis only and not natriuresis in hen . Natriuretic specific activity values 
were high in rat and mouse atria (De Bold and Salerno, 1983).
Table 3. Summary of the more important effects of ANP 
(Natriuresis-Diuresis) in different species.
Site of secretion pffect
Species Atria Ventricle Natriuresis Diuresi
Human + + +
Frog + + + +
Hen — + — 4-
Rat & Mouse + — + —
4.3-2 On the heart and blood circulation
Injections of synthetic atriopeptin III (Serl03-Tyrl26) or atriopeptin EE (Ser 
103 - Arg 125 ) reduced cardiac output in anaesthetised dogs and rats 
(Natsume et al., 1985; Smiths and Lappe, 1985) however the output was 
not significally altered after injection of ANP (Argl01-Tyrl26) (Siegel et al., 
1984). ANP is a vasorelaxant and blood pressure reducer (Sagnella et al., 
1985; Anderson et al., 1986; Richards, 1986). Low dose infusion of ANP 
(0.75 pM/kg.min. ie: 0.0023 qg/kg.min) in six normal men resulted in a 
small increase in plasma ANP within the range established for normal men 
and women (5-24 pM ) and a significant reduction in systolic blood pressure 
(Richards et al., 1988).
ANP relaxes rabbit aorta precontracted with noradrenaline or histamine
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(Currie et a l, 1984), but gives poor relaxation with those contracted with 
K+ (Garcia et aL, 1984). Atriopeptin II (10 ^M) inhibits intracellular Ca++ 
release in vascular smooth muscle caused by noradrenaline, histamine 
(lO-^M) and caffeine (25 mM) (Meicheri et al., 1986). The decrease of 
cytosolic Ca++ in vascular smooth muscle cells (rat) by the activation of 
cGMP dependent protein kinase, results in relaxation of these cells (Lincoln 
and Johnson, 1984). Owen et al., (1987) concluded that ANP stimulates Na+ 
-K+ -Cl - cotransport in vascular smooth muscle cells through the elevation of 
intracellular cGMP.
4.3-3 On the adrenal gland
An infusion of 15pmol/min of a-hANP inhibited angiotensin Il-stimulated 
aldosterone release in normal subjects ( Anderson et al., 1986). Natriuresis 
was enhanced, plasma aldosterone and adrenaline concentrations were 
depressed and blood pressure lowered due to an intravenous injection of ANP 
(Richards et al., 1985). ANP induces the secretion of arginine-vasopressin 
from the isolated posterior lobe of the hypophysis (Januszewicz et al., 1986) 
but inhibits aldosterone and cortisol secretion from adrenocortical tissue 
stimulated with angiotensin II, ACTH and K+ (Chartier and Schiffrin, 
1987).
4.4 ANP receptors
ANP receptors with different K^s are distributed in several tissues (table 4) 
according to the degree of involvment of these areas in the regulation of the 
blood pressure and the other fluids in the body. The is in the picomolar 
range in most studies. Although most of the binding studies revealed a single 
class of high affinity binding sites whether radio-iodinated synthetic ANP or 
a quantitative autoradio graphic method was used, few of these studies 
showed more than one class of binding sites. The number of sites per cell or
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per mg of protein varies according to the tissue and their involvment in 
translating ANP signals. Receptors for ANP have been detected in the zona 
glomerulosa of the adrenal cortex, renal glomeruli, collecting ducts and all 
areas in the brain involved in regulation of blood pressure, sodium and water 
(Genest, 1986). Binding sites were found in vascular and epithelial tissue in 
the lung, the bases of intestinal villi, in ciliary bodies of the eye (Bianchi et 
al., 1985) and in the anterior pituitary (Quirion et al., 1984) although ANP 
had no effect on the anterior pituitary hormone secretion (Abousamra et al., 
1987). Receptors for ANP were found in cultured neuroblastoma cells 
(N4TG1) of peripheral origin (Pandy et al., 1987), Human platelets contain 
specific receptors for ANP; but red and white blood cells do not (Schiffrin et 
al., 1986). Specific binding sites for ANP were detected in cultured vascular 
smooth muscle cells (VSMC) of the rat aorta (Hirata et al., 1984). Blood 
vessels (mesenteric & renal arteries) and adrenal capsules bear specific 
receptors for r-ANP (Schiffrin et al., 1985). ANP specific receptors were 
detected in the subfornical organ and choroid plexus in water-deprived rats 
(Saavandra et al., 1987). Gibson et al., (1986) have studied ANP receptors 
distribution in rat brain using a quantitative autoradiographic method. They 
found the highest levels of ANP receptor in the circumventricular organs and 
the olfactory apparatus and moderate levels in the mid brain and brain stem 
but the lowest levels were found in the forbrain dienciphalon, basal ganglia, 
cortex and cerebellum. All the areas in the brain, which are known to be 
involved in the regulation of blood pressure, renin-dependent hypertension 
and in the regulation of water and sodium homeostasis, contain ANP 
receptors (Genest, 1986). Specific receptors for ANP have been identified in 
cultured mesenchymal nonmyocardial cells in rat heart (Hirata et al., 1985). 
Vollmar et al., (1988) have demonstrated specific receptors on the corpus
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luteum. Specific high-affinity binding sites for ANP in the clone D384 
derived from the human astrocytoma cell line have been recently demonstrated 
and furthermore, these binding sites were coupled to guanylate cyclase 
(Lyall et al., 1988).
4.5 Signal transduction
Receptors for ANP are localized on the external surface of the plasma 
membrane and the cyclic nucleotide guanosine 3', 5' monophosphate 
phosphate (cGMP) mediates the action of this peptide on target cells. ANP 
was found to inhibit cyclic adenosine 3', 5' monophosphate activity (cAMP) 
( Anand-Srivastava et al., 1984 ). It is worth pointing out that ANP is unique 
in selectively activating the particulate form (membrane-associated) of 
guanylate cyclase in PC12 ceUs ( Fiscus et al., 1987).
The increase of cGMP in LLC-PKl kidney epithelial cells, was time and 
concentration dependent after addition of ANP, A VP and oxytocin. 
However, unlike ANP that A VP and oxytocin activated the soluble guanylate 
cyclase instead of the particulate form. In the presence of methylene blue, 
which is an inhibitor of the soluble form of the enzyme, the ANP-induced 
increase in cGMP was not altered nor was the accumulation of cAMP by AVP 
and oxytocin. This has confirmed the activation of the soluble form of the 
enzyme by AVP and oxytocin ( Leitman et al., 1988).
The increase of cGMP accumulation in aortic smooth muscle cells induced 
by ANP is inhibited by angiotensin II and other calcium mobilizing stimuli. 
(Smith and Lincoln, 1987). ANP increases the production of cGMP in aortic 
tissue (Hirata et al., 1985), adrenal gland (Hinko et al., 1987), kidney 
(Takeda et al., 1986) and PC 12 rat pheochromocytoma cells in culture 
(Fiscus et al., 1987). Human and rat ANPs stimulated cGMP in avian 
epiphyseal growth plate chondroprogenitor cells and avian skin fibroblasts but
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they did not alter the basal cAMP concentrations (Pines and Hurwitz, 1988). 
The accumulation of cGMP in many areas of the brain by ANP was pointed 
out by Fiscus et al„ (1987). In summary cGMP appears to play a major role 
in the translation of ANP signals in the cell.
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5. The aim of the project
The PC 12 cell line used in these studies is derived from a 
phaeochromocytoma of rat adrenal chromaffin cells. They have been 
investigated as firstly a site of action and as a source for vasoactive hormones 
and secondly as a possible model of normal chromaffin cell secretory 
function.
Receptors for the pressor hormone angiotensin II and for the vasorelaxing 
hormone, atrial natriuretic peptide were sought and characterised since brain 
and normal medullary tissue are known to secrete vasoactive hormones, 
PC12 cells were investigated for the presence of ANP and for elements of 
the renin angiotensin system. Preleminary attempts were made to study the 
content of ANP secretion.
The type(s) of catecholamine(s) released by PC12 cells were also identified. 
The influences of K+ depolarisation, ANP on the release of the major 
catecholamine secretory product, dopamine, were also considered using both 
static incubations and perfusion system .
For future studies the NGF-treated PC 12 cells in culture (which resemble 
sympathetic neurons) may well be a useful system for studying ANP presence 
within the brain, since it is difficult to handle neurons for long periods in 
culture.
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Materials and Methods
6. Materials and methods
6.1 Materials
All and ANP fragments were obtained from Peninsula Laboratories (UK), 
Angiotensin II, bradykinin, arginine-8-vasopressin and Tween 20 were 
obtained from Sigma (UK)4^^I-rANP (99-126) and ^^^I-A II (human) and 
3H-dopamine were obtained from Amersham International. Foetal calf 
serum and other media were obtained from GIB CO BRL, The remaining 
chemicals were also obtained from Sigma (UK).
6.2 Cell culture
PC12 cells were obtained from Dr. A. McCruden (University of 
Strathclyde, Scotland) and Dr. Peter Clark (University of Glasgow). Cells 
(5x10^) were frozen at -70 °C in 1 ml of freezing mix composition (9 ml of 
foetal calf serum + 1 ml of dimethyl sulfoxide (DMSO). To start a culture 1 
ml of frozen cells ( 5x10^) was thawed out and added to 75cm^ tissue culture 
flasks containing 20ml of growth medium (section 6 .8-1) and left for 2 days 
to allow the cells to recover. The medium was changed daily thereafter. 
When the cells became confluent they were passaged as follows. The 
medium was removed and the monolayer rinsed twice with 10ml of hepes 
saline (HS) and then 5mis of trypsin/versene [5 ml of trypsin (0.25%) in HS 
(section 6.8-2)+20 ml of versene] (T/V) was added. After approximately 5 
min the cells started detaching from the flasks. To stop further effects of 
T/V, 10ml of growth medium was added to the flasks. The cell suspension 
was collected in a sterile universal container and then trituated using a pasteur 
pipette until a single cell suspension was obtained. Cells were counted with a 
haemocytometer and added to 75cm^ tissue culture flasks at a concentration of 
4 million cells per flask. Each flask contained 20ml of growth medium
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(6.8-1) and was maintained at 37°C in a 5 % CO^ , 95 % air, humidified 
atmosphere. Cells were used at confluence approximately one week later.
6.3 Binding studies
6.3-1 Plasma membrane preparation
3 flasks (75cm^) of confluent cells were used for each experiment (Fig.7). 
Cells were scraped from the flasks using a cell scraper ( Costar , 
Cambridge, MA.), pelleted by centrifugation at 2000 rpm for 5min at 10°C 
and then resuspended in ice-cold 250 mM sucrose (5ml). They were then 
homogenized (2xl2sec) with a Polytron PTA 20S homogenizer (Kinetic, 
Denmark). The homogenate was then centrifuged (40 000 rpm for Ih at 4°C 
) to obtain the membrane fraction. The membrane was then resuspended in
buffer Tris/NaCl containing(mM) : Tris (50), NaCl (150), KCl (3.6), MgCl^
(1.8), CaClj (5), pH 7.35, at 0°C. Membranes were stored on ice and used
fresh on the day of preparation.
6.3-2 Protein estimation
Protein concentration was estimated using the method of Lowry et aL, 
(1951).
The following solutions were prepared:
A ) 2% W/V Na^COg (anhydrous) in 0.1 NaOH
Bl) 2% W/V Cu SO4
B2) 4% NaK tartarate tetrahydrate in H^O
C) 100ml of (A) was added to [ 2.5ml (Bl)+2.5ml (B2)]
D) Folin (yellow) Ciocaltean's Phenol Reagent was prepared by adding 
5ml of the stock solution to 3ml of distilled water. Bovine serum albumin 
(BSA) (0. Img/ml- Img/ml) dissolved in distilled water was used as a protein
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Fig.7. The binding experiments
3 confluent ^5cnf flasks
Medium poured off, cells scraped in 5 ml of 
HBSS and collected into universal containers.
Centrifuged at 2000 r )m for 5 min at l(f C.
' r
Pellet resuspended in 5 ml ice-cold sucrose solution. 
Homogenized for 2 x 12 sec with 30 sec gap.I
The homogenate centrifuged ( 40000 rpm for Ih at 4°C).I
Pellet resuspended in 4 ml of Tris/NaClI
Protein estimated according to Lowry et al., 1951. See 6.3-2.
IlOOql of I-ANP was added to all tubes. Count 3 tubes as total 
counts in gamma counter
25pi of r-ANP in Tris/BSA was added to non-specific binding tubes. 
25 pi of Tris/BSA was added to ^ e  total binding tubes as control.
lOOpl ( 50pg) of protein was added to all tubes
Incubated f^r Ih at 0°C.
5 ml of Tris/NaCl containing 0.1% BSA was added to tubes and then 
filtered through 0.45pm membrane filters pre-wetted with Tris/BSA 
containing 0.1% Tween 20, Filters dried and counted using gamma
counter.
standard.
Procedure
200|xl of each standard, membrane preparation or Tris/ NaCl (used as a 
blank) was added to plastic disposable tubes. 2.5ml of solution C was added 
to each tube, mixed, left for 10 min and then 250 pi of solution D was 
added, left 60 min at room temperature, and then the absorbance was read at 
700nm using a Unicam SP 18CX) Ultraviolet Spectrophotometer.
6.3-3 Binding conditions
Tubes contained membrane (100 pi, 50 pg of protein) in Tris/NaCl and 100 
pi of ^^^1-rANP (99-126) (7.8 pM-1 nM) in Tris/NaCl containing 1% bovine 
serum albumin (Tris/BSA) as a carrier. Non-specific binding was defined as 
radioactivity not displaceable by the addition (25 pi) of rANP (99-126) at a 
final concentration of 1 pM. Initial kinetic experiments were performed at 
0°C, 22°C or 37°C but all subsequent experiments were performed at 0°C. 
Bound tracer was separated from free tracer by the addition of 5ml of ice-cold 
Tris/NaCl containing 0.1% BSA followed by immediate filtration through 
0.45 pm membrane filters (Millipore HAWP) pre-wetted with Tris/BSA 
containing 0.1% Tween 20. The filters were washed with a further 5ml of 
filter buffer, dried and radioactivity counted in a Nuclear Enterprises 1612 
gamma counter. Non-specific binding to the filters, estimated throughout the 
range of tracer used, amounted to less than 0.5% of total counts.
6.3-4 Tracer degradation
Membrane breakdown of ANP tracer during incubation was determined by 
high-performance liquid chromatography. After Ih the incubation mixture 
was centrifuged to pellet the membrane and the supernatant removed for 
analysis using a Gilson model 303 HPLC with a C l8 ultrasphere ODS 
column (5pm, 4.6 cm x 25 cm), a gradient of 0-60% acetonitrile in 0.1%
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trifluoroacetic acid and a flow of 0.5ml/min. The fractions collected were 
measured for radioactivity.
6.4 Catecholamine assay
Most phaeochromocytoma cells synthesise noradrenaline and rarely 
adrenaline as final catecholamine products (Kuchel, 1983). The release of 
noradrenaline from cultured PCI2 cells under depolarizing conditions has 
been documented (Shalaby et al., 1984) (Kongsamut and Miller, 1986), 
while Melega and Howard, (1984) Nagatsu et al., ( 1987) and Ahnert-Hilger 
and Gratzl, (1987) have reported the release of dopamine from cultured PC12 
cells. This present study was to find out whether this clone of cultured 
PC 12 cells secreted adrenaline, noradrenaline or dopamine.
6.4-1 Method
6 flasks (25cm^) of confluent PC12 cells were used for the experiment 
(Fig.8). Flasks were rinsed twice with H2 medium and then exposed to 
either 5 or 70 mM K+ for either 0, 5 or 30 min. The solutions were decanted 
and frozen immediately at -70 °C.
A radio-enzymatic assay (B allet a/., 1981) was used to identify the 
catecholamines released. With this method the enzyme Catechol-O-Methyl 
Transferase (COMT) catalyses the transfer of the ^H-methyl group from 
^H-S-adenosyl-methionine (^H-SAM) to catecholamines (adrenaline, 
noradrenaline and dopamine) present in the sample. The 3-methoxy 
derivatives formed were thus labelled with a methyl group.
After méthylation the samples were extracted with an organic solvent and 
then separated by thin layer chromatography (TLC). The metabolites were 
visualised under UV light and scraped off into a tube containing 0.01 M 
NH4 OH to extract the samples from the silica. The 3 methoxy derivatives of
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Fig.8. Catecholamine assay
6 confluent 25 cn?flasks
Rinsed twice with 5 ml of H2
exposed either to 5 or 70 mM K for 0,5 or 30 
min. Collected and frozen immediately
COMT catalysed the transfer o f H-methyl group from 
^H-S-adenosyl methionine to catecholamines present in samples
After the méthylation, samples extracted with 
organic solvent and then separated by TLC
Metabolites visualised under UV and scraped 
off into tubes containing 0.01 Nl^OH.
3 methoxy derivatives of 3 methoxy derivatives of
adrenaline oxidised by NalQ noradrenaline oxidised by
to vanillin NalO^to vanillin 4
3 methoxy tyramine acetylated by 
acetic anhydride to 3 methoxy 4 
acetoxy tyramine
Radioactivity determined by a scintillation counter
noradrenaline and adrenaline were then oxidised to vanillin and the 3 
methoxy tyramine acetylated to facilitate their uptake into scintillation fluid. 
The radioactivity in the samples was then determined in a scintillation counter.
6.5 Effect of ANP on ^H-Dopamine release from PC 12 cells 
Having identified ANP receptors on PCI2 cells, and that the cells secreted 
dopamine, it was of interest to test the hypothesis that ANP might act 
directly to inhibit catecholamine release. Two methods were used. The dish 
method had the advantage of simplicity, whereas the perfusion method 
reduced the artefacts associated with solution changes, and has the potential 
to achieve better time resolution.
6.5-1 Dish method
These experiments were performed using a method modified from Shalaby et 
aL, (1984), Kongsamut and Miller, (1986) and Ahnert-Hilger and Gratzl,
(1987) (Fig.9). Cells were plated in petri-dishes (60 x 15 mm ) treated with 
Gelatin/Poly-L-Lysine [20mls of 2% gelatin+2mls of poly-L-lysine (10 pg/ml 
working solution)] at a concentration of 1 million per dish and grown in the 
standard PC 12 cell culture medium (section 6.8-1). Cells were used at 
confluence approximately 3-4 days later. Cells were washed once with 
DMEM, supplemented with ImM ascorbic acid as an anti-oxidant, and then 
loaded with (2,5,6 ^H-dopamine (O.lp Ci/ pi) at a concentation of 3 pM for 
2h in 2 mis of DMEM supplemented with ImM ascorbic acid. This was 
followed by a wash period whereby for a total of 30 minutes a 2ml solution 
containing 5mM K+ (composition 6.8-5) was added to the cell monolayer, 
left 5min, removed and replaced with fresh solution. For the experimental 
period, six further solution changes were made at 5 min intervals. To study 
the effect of increasing the concentration of K+ on ^H-Dopamine release, 
control dishes received 5mM K for all 6 samples and experimental dishes
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Fig.9. Dish method.
6 confluent coated petri dishes
Rinsed once with DMEM suplemented with 
ImM ascorbic acid and then loaded in 2ml of 
the same solution with  ^H-dopamine for 2h 
at37^C. I
Cells were washed every 5 min over 30 min 
with SmMK*" to remove excess label.
I
The experiment started by adding 2ml of :
I
(2 dishes) (2 dashes ) (2 dishes )
2x5 mMK^changes 2x5  mMldchanges
2 x 5 mMI^ichanges i
2x5 mMKTchanges 2x5  mMK^changes
I I
2x5  mVfidchanges 
2 X 37 mlS^changes 2x70 mMICthanges
2x5  mMK*changesI
Samples were collected at 5 min intervals
I
At the end of each 30 min 2 ml of lauryl sulphate was added to each dish, 
collected into vials and aU vials counted using in a scintillation counter
received either 37mM K+ or 70mM K+ (composition section 6 ,8-6—6.8-7) 
in the third and fourth sample followed by 5mM K+ for the remaining 
samples, as for the control. The 2ml samples, after being removed from the 
cells were saved, and radioactivity in them counted in a scintillation 
counter. At the end of each experiment cells were still attached to the dishes 
and 2ml of lauryl sulphate (0 .2 %) was added to each dish to determine 
remaining intracellular  ^H-dopamine. For each experiment the release of 
^H-dopamine from the cells is expressed as a percentage of radioactivity 
present in the cells prior to the paticular release period. These experiments 
were carried out at 37°C in duplicate. The three different concentrations of 
potassium were used because of the difference in their ability to depolarize 
these cells (Hodgkin and Huxley, 1952).
Even though much care was taken not to disturb the attached cells when 
exchanging the solutions (5, 37 or 70 mM K+) a few cells still came off 
especially from the edges. This might affect the radioactivity measured in the 
supernatant.
6,5-2 Perfusion system (Fig.lO).
Each experiment used 2 million PC12 cells in suspension (Fig. 11). To avoid 
risk of proteolytic damage to ANP receptors through trypsinisation, cells were 
left in 10 ml of normal medium at room temperature for 5-10 min until they 
detached from their culture dishes and triturated to produce a single cell 
suspension. Cells were then loaded with ^H-dopamine for 2h as described 
above. They were then loaded onto Whatman GF/B Glass microfibre filter 
paper. A wash period followed whereby for a total of 30 min cells were 
washed with 5 mM K+ solution and then perfused with 5 mM K+ or 70 
mM K+ solutions using the following modified method of Whitton et al.,
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rr
70mM K 37mM K 5mM K
Interchangeable syringe 
and tap assemblies
Syringe containing 
solution to be tested
Controlling tap
Cells
Filter paper
Clamp
Tubing
Peristaltic
pump
Scintillation vials 
2 ml fractions 
collected at 5 min 
intervals.
Fig.lO. The perfusion system
F ig .ll. The perfusion method
4 million cells in suspension loaded with H-dopamine, 
incubated at 37° C for 2h.
Control
2 million cells loaded onto the 
filter paper, washed with 5mMK^ 
for 30 min.
i
tExperiment
2 million cells loaded onto the 
filter paper, washed with 
5mMBv for 30 min
i
The cells were perfused with 5 mMld" 
solution for 10 min
The cells were perfused with 5 mMK*" 
solution for 10 min
I
The cells were perfused with 5 mMK  ^
solution for 10 min
The cells were perfused with 5 mMK** 
solution for 10 min
i
The cells were perfused with 70 m M lv' 
solution for 10 min
i
i
* The cells were perfused with 5 mMK  ^
solution for 10 min
The filter paper along with cells on top of it were put in vials 
containing 2 ml lauryl sulphate, count aU vials in scintillation 
counter.
For ANP modulation experiments, ANP was added 
at final concentration of 10"^  M to aU perfusion solutions.
(1988). The filter paper was held in a clamped 10 mm diameter filter holder 
(Swinnex filters) and a 5 ml syringe with tap was attached to the filter to allow 
washing with defined solutions (Fig.lO). After the wash period, the pump 
was stopped, the syringe removed and a prepared 5 ml syringe filled with 5 
mM K+ was replaced, the pump was restarted and the collection of the 2 ml 
of perfused solution started after the last drop of previous solution was 
pumped out. The same procedure was employed for solution changes with 
other syringes filled with 5 mM K+ +ANP, 70 mM K+ or 70 mM K+ +ANP. 
2ml samples were collected into scintillation vials (6 samples over 30 min) 
through a Microperpex (LKB) peristaltic pump. The syringe changing 
procedure took less than 1 min. To test the effect on ^H-dopamine release 
from PC 12 cells perfused with either 5 mM K+or70 mM K+ the following 
procedure was carried out. In the first experiment two parallel systems were 
set up whereby one set of cells was perfused with 5 mM K+ for 30 min and 
the other with 5 mM K+ containing a final concentration of IQ-^M ANP.
ANP was used at lO'^M because this was well above the determined 
previously in the binding studies (nM range), receptors would be saturated 
and so any effects would be maximal. In a second set of two parallel 
experiments, cells were perfused for 10 min with 5 mM K+, then for a 
further 10 min with 70 mM K+ and finally for the last 10 min with 5 mM 
K+. Again, one of the two experiments contained lO^M ANP throughout. 
20ml of scintillation fluid was added to each vial and then radioactivity in the 
samples was determined in a scintillation counter.
The delay calculated between the changes of solutions in this perfusion 
system was less than 1 min in total, in other words the tubing system was 
short to reduce the lengh of time used by the solutions reaching the cells on
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the filter and moving along the tubing to the vials. The volume of the filter 
and tubing downstream of the cells was <1 m l.
6.6 ANP secretion
Recently Ong et al, (1987) have demonstrated the co-existence of ANP 
(99-126) and its precursors within the bovine chromaffin granules. These 
investigators have comfirmed the maturation process of atrial peptides in the 
adrenal medulla.
The presence of ANP in the adrenal medulla suggested the question as to 
whether these PC 12 cells secrete ANP or not.
For this assay, several methods were used ;
1) PC 12 cells were left in 10 ml of normal medium at room temperature until 
they detached from their culture flasks (Fig. 12). 2 noillion cells were then 
loaded onto Whatman GF/B G Glass micro filter paper and perfused with 2 
different concentrations of potassium (5 or 70mM K+ ) using the same 
modified method of Whitton et al., (1988) described in section 6.5-2. 2 ml 
samples were collected into scintillation vials dipped in liquid nitrogen to 
freeze them immediately six samples were taken at 5 min intervals and tested 
for ANP secretion.
2) Six ( 25 cm^) coated confluent flasks were used (Fig. 13). The culture 
medium was removed and cells were rinced twice with H2 at 37 °C. 2ml of 
5mM K+ were added to 2 flasks as a control, 2ml of 70mM K+ were added 
to 2 flasks and 2 ml of the same medium supplemented with protease 
inhibitors were added to the other 2 flasks. The six flasks were incubated for 
5 min at 37 °C; the medium was then collected and frozen immediately in 
liquid nitrogen. The samples were then tested for ANP secretion.
3) The supernatant prepared for renin assay (section 6.7-1) was also assayed 
for ANP presence in PC 12 cells.
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Fig.l2. Perfused PC 12 cells
1 flask (75 cm ) of PC12 ceUs
I
Medium poured off, 10 ml of growth medium 
were added, left 10 min at room temperature, 
detached, collected into a universal container
?
Control
2 million cells loaded 
onto filter paper
Cells were perfused with 
5 mM Ej for 10 min
Cells were perfused with 
5 mMKTor 10 min
I
Experiment
2 miUion cells loaded 
onto filter paper
Cells ^ r e  perfused with 
5mMK^ for 10 min
Cells were 
70mMld'
nerfused with 
or 10 mm
I
Cells were perfused with 
5 mMK; for 10 min
Cells were perfused with 
5 mMK*' for 10 min
I
2 ml fractions were collected at 5 min intervals into 
unversal containers dipped in liquid nitrogen
ANP extraction and radio-immuno^say was 
performed as in Fig. 14
Fig.l3. Flask method
6 confluent coated 25 cir? flasks
I
Pour off medium
I
Rinse twice with H2 at 37°C
2 flasks 2 flasks 2 flasksL i I5 ml of 5mMK\vere 5 ml of 70mMK*'were 5 ml of 70mMICsupplemented
added aHHpd with protease inhibitors were
added (see 6 .8-8 )
Incubated for 5 min at 37°C
I
Samples collected and frozen immediately
I
ANP extraction and radio-immunioassay was 
performed as in Fig. 14
6.6-1 ANP extraction
All these three preparations were assayed according to Richards et al., (1987). 
Samples were acidified by adding each 1 ml of sample to 0.25 ml of 2N HCl. 
The acidified samples were centrifuged (2000 rpm, at 4°C for 10 min).
The extraction of ANP from 1-4 ml acidified samples took place on
reverse phase columns (Sep-Pak Waters Associates). Sep-Paks were 
pre-activated with 5 ml methanol and washed with 5 ml distilled water prior to 
application of the acidified sample.
A wash period followed where 15 ml of trifluoroacetic acid (TFA, 3 x 5  ml) 
were run through and the adsorbed peptide was eluted with 2 ml of 60% 
acetonitrile (v/v ) 0.1% TFA into plastic tubes. The extracts were dried under 
compressed air and reconstituted in 0.5 ml buffer (Fig. 14).
6.6-2 ANP radio-immunoassay
Synthetic a-hANP was diluted (100—0.4 pg/tube) in buffer A (100 mM 
sodium phosphate pH 7.4 containing 50 mM NaCl, 0.1 % w/v bovine serum 
albumin, 0.1 % w/v Triton x-100 and 50 kallikrein inhibitor units/ml 
trasylol). For extracted methods, 100 pi of the sample (standard solution, or 
reconstituted plasma extract ) 100 pi of the ready prepared antibody at a final 
dilution of 1/25 000 and 2 pg a-hANP in 50 pi of the buffer, were 
incubated at 4 °C for 24h. All assays were set up in duplicate. Separation of 
free and bound ligand was achieved by mixing with 1 ml dextran-coated 
charcoal ( Norit GSX charcoal 3g, and dextran T-70 310mg in 500 ml 
Tris/buffer B: 50mM Tris/HCl pH 7.4. 5mM EDTA, 0.1% BSA). The 
mixture was immediately centrifuged for 20 min at 2°C and the free label was 
counted ( Fig. 14).
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Fig,14. ANP extraction
Samples acidified (1 ml of sample+0.25 ml HCl)I
Centrifuged (2000 rpm) at 4°C for 10 
min I
Extract 1-4 ml on Ci g reverse phase columns. 
SepPak pre-activated with 5 ml methanol, washed 
with 5 ml distilled water
Washed with 15 ml of TFAI
Adsorbed peptide eluted with 2 ml of 60 % 
acetonitrile (v/v) 0.1 % TFA into plastic tubesI
Extracts dried and reconstituted in 0.5 ml phosphate 
buffer I
a-hANP diluted in buffer A (see text) (100-0.4 pg/tube)
I
lOOjul of sample, 100pi of antibody (1/25 000) and 
2pg hANP in 50pl of buffer. Incubate at 4°C 
for 2h. I
1 ml dextran-coated charcoal (Norit GSX charcoal 3g, and 
dextran T-70 310 mg in 500 ml Tris buffer B (see text)
1
The mixture was immediately centrifuged for 20 min at 
2 °C and the free label was counted.
6.7 Measurement of intracellular renin in PC 12 cells in culture
Patients with hypertension caused by an excess of circulating catecholamines 
released by phaeochromocytoma have been reported to show increased 
plasma renin activities and aldosterone levels (Vetter, 1975). For such 
reasons these rat PCI2 cells were tested for their ability to secrete renin,
6.7-1 Cell preparation
PC 12 cells were cultured as described earlier. Ten (150 cm^) confluent 
collagen-coated flasks were used for the experiment (Fig. 15). Half of the 
cells were trypsinized since trypsin is known to activate renin. The other half 
of the cells were scraped from the flasks. The medium was poured off and 
the monolayers then washed twice with HS (2x10ml). Any remaining traces 
of HS were removed using a pasteur pipette. A further 5ml of either cold HS 
or trypsin were then added to each flask. Half of the cells were scraped from 
the flasks using a cell scraper (Costar, Cambridge, MA). Trypsinized and 
non-trypsinised cells were collected into universal containers and centrifuged 
at 200g for 5min at 5°C. Two ml ice cold Tris/HCl (100 mM ) pH 7.4 was 
then added to each pellet. The pellets were then homogenized (2x10 sec ) 
with a polytron PTA20S homogenizer (Kinematic, Denmark), care being 
taken to keep the preparation cold and pelleted by centrifugation at 40 000 rpm 
for Ih at 5°C. The two supernatants were removed and frozen immediately 
at -70 °C until the renin radioimmunoassay was carried out.
6.7-2 Renin assay
Renin was assayed by an indirect radioimmunoassay (Morton and Wallace, 
1983) as follows. Renin samples were incubated with renin substrate 
(angiotensinogen) for predetermined times. At the end of the incubation the 
reaction was stopped by placing tubes on ice and the Al generated was
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Fig.15. Renin assay
10 confluent coated 150cm flasks
5 flasks, medium poured off, cells 
washed twice with HS
5 ml of T/V were added to each 
flask for 5-6 min.
5 flasks, medium poured off, cells 
washed twice with HS
ICeUs in each flask were scraped 
in 5 ml of cold HS
Cells coUected into universal containers 
centrifuged at 2000 rpm for 5min at 5tZ
I
Pellets were homogenized in 2 ml of ice-cold 
Tris/HCl I
Centrifuged at 40 000 ^ m  for Ih at ^C, 
supernatant frozen. I
I
IOn the day of the experimentI
lOpl of supernatant was added to 
25 pi of human serum albumin (in 
duplicate )
Duplicate tubes were set up for 
standard curves. 200-1.6 pg of Al 
(351Û) was double dUuted
20pl of renin substrate was added to aU 
tubes, incubated for land 4h at 37° C.
Removed from water bath and replaced 
on ice, 300pl of Tris/HCl (lOOmM) was 
added to aU tubes
I
I 
o P h -A l  wis
300|Jl of Tris/HCl (lOOmM) 
was added to 5 LP3 tubes
50pl f "1 I 5  added to all tubes 
and incubated overnight at 5°C.I
1 ml of charcoal was added to tubes except the 5 totals, spun for 5 min, the 
supernatant removed, and pellets counted using gamma counter.
detected by standard radioimmunoassay.
On the day of the experiment, duplicate samples of the stored supernatant 
(10 pi) were added to 25 pi of human serum albumin (HSA) and 20 pi of 
ready prepared angiotensin I antiserum (981/7 diluted 1:80 in 3M Tris/HCl 
pH 7) and rat renin substrate in a ratio of 1: 6 . The mixture was then 
centrifuged for 5 min at 5°C and incubated at 37°C for various times (0, 1 
and 5h ). Duplicate control samples were kept on ice and these were called 
time 0 samples. Standard curves (Fig. 16) were set up as follows. Duplicate 
tubes contained 200-1.6 pg of A I (35 pi). To these tubes 20 pi of A I 
antiserum/ renin substrate was added and then the tubes were incubated for 
the same length of time as the renin samples. At the end of the required 
incubation period samples were removed from the water-bath, and 300 pi of 
ice cold Tris (100 mM) pH 7.4 was added to stop further renin activity.
50 pi (5pg) of i^I-A I was added to all tubes. Samples were mixed and then 
incubated at 5°C overnight. 1ml of charcoal was added to each sample to 
bind free i^^I-A I, and then the samples were spun for 5 min at 5°C to pellet 
the charcoal. The supernatant was then removed carefully and the charcoal 
pellets were counted using a gamma counter (Nuclear Enterprises 1612 ).
6.8 Media recepes
6.8-1 Growth medium
ml
Eagle's water 134
X 10 concentrated GMEM 16
7.5% bicarbonate sodium 5
* Antibiotics (GPS A) 5
Horse serum 20
Foetal calf serum 20
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Final concentration in the gi’owth 
medium.
^Glutamine 2.85 mM
^Penicillin 47.6 units/ml
^Streptomycin 27.3 pg/ml
* Amphotericin B 0.29 pg/ml
6.8-2 Calcium and magesium free Hepes Saline (HS)
g/1 mM
NaCl 8 140
KCl 0.4 5
Glucose 1 5
Hepes 2.388 10
Phenol red (0.5%) add 2ml/l 0.003
pH to 7.4 with 5M NaOH
Sterilised by autoclaving at 121 °C for 20 min and stored at 4 °C
6.8-3 Balanced salts solution (Hank's Hepes,H2)
mM
NaCl 8 140
KCl 0.4 5
CaCl2 0.14 1
MgCl2 0.2 1
D-Glucose 1 5
Hepes 2.388 10
Phenol red (0.5%) add 2mlA 0.003
pH to 7.4 with 5M NaOH.
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Sterilised by autoclaving at 121 °C for 20 tnin and stored at 4
6.8-4 Versene
gIL mM
NaCl 8 140
KCI 0.2 2.5
Na2HP0 4 1.15 8
KH2PO4 0 .2 1.5
EDTA (di-sodium salt) 0 .2 0.5
0.5 phenol red: add 2 ml /I 0.003
Sterilised by autoclaving at 121 °C for 20 min and stored at 4 °<
6.8-5 5mM K+ solution
Reagent mM
Choline chloride 11,97 86.1
NaCl 2.92 50
KCI 0.37 5
CaCl2 0.14 1.3
KH2PO4 0.05 0.44
Na2HP0 4 0.04 0.34
NaHCOg 0.22 2.62
MgS0 4 0.09 0.81
Ascorbate 0.17 1
Pargyline 0.015 0.1
Desmethylimipramine 0.019 0.1
Glucose 1.008 5.6
Hepes 4.7 20
3 8
0.5 % Phenol red add 2ml/l 0.003
Adjust the pH to 7.4 with HCl
6.8-6 70mM K+ solution
As above except for : ^  ihM
Choline chloride 21.1 2.93
KCI 70 5.21
6.8-7 37mM K+ solution Made up as required as 1:1 dilution of 5mM 
K+ and 70mM K+ solutions.
6.8-8 The secretion medium:
For ANP secretion assay these proteases were added at the final concentration 
shown below to the 70mM K solution.
gd mM
Aprotonin 0.0065 0.001
Leupeptin 0.00047 0.001
Pep statin A 0.00068 0.001
1,10 Phenanthroline 0.018 0.01
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Fig.l6. Renin standard curve for Ih.
Results
7. Characterization of the PC 12 cell ANP receptor
In this section a characterization of the rat PC 12 cell ANP receptor is 
described. A comparison of the results of this study with those already 
published for other ANP adrenal receptors is included.
7.1 Specific binding as function of membrane protein 
concentration
The binding of ^^^I-labeled ANP to the PCI2 membrane preparation 
increased with increasing concentrations of protein, and remained linear up 
to 100 pg/100 jol (Fig. 17), These experiments were carried out on ice for 60 
min.
7.2 Kinetics of specific binding
Specific binding of ^^^I-ANP to the membrane fraction was time and 
temperatiu'e dependent, 100 pi (50 pg protein of the PC12 cell membrane 
preparation was incubated with 100 pi of ^^^I-labeled ANP (0.2nM) and 25 
pi of either ANP (final concentration 1 pM) or Tris/BS A for increasing times 
up to 2h. At 0°C there was a progressive increase in binding with time, 
plateauing after 45 min (Fig.18 a). In contrast at 22“C, binding was maximal 
by 30 min and declined rapidly thereafter (Fig.18 b). At 37°C binding was 
very rapid, but unstable (Fig.18 c).
7.3 Degradation of ^^^I-ANP
Membrane degradation of r-ANP tracer during the incubation was determined 
by high performance liquid chromatography (HPLC). HPLC showed marked 
degradation of the tracer in the presence of membrane at 22°C and 37°C (14% 
and 3.6% remaining intact after 1 hour respectively ); whereas at 0°C over
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Fig.17: Binding of ^^^I-rANP (99-126) to a plasma membrane 
preparation as a function of membrane protein concentration.
Incubation was for 60 min at 0 °C. Points are the mean ± SE of 4 separate 
experiments each performed in triplicate. Empty squares denote total binding; 
filled squares specific binding; dots, nonspecific binding.
Fig.18: Specific binding of ^^^I-rANP (99-126) to a plasma 
membrane preparation as a function of time at 22**C and 
37°C.
Points are the mean ± SE of 4 separate experiments each performed in 
triplicate.
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70% remained intact compared with ANP which had not been incubated with 
membrane (90% intact ) (Fig. 19). Subsequent experiments were therefore
carried out at 0°C.
7.4 Saturability of specific binding
Binding of i^^I-labeied ANP to the PC12 membrane preparation with 
increasing ligand concentration was then studied. 100 jal of membrane 
preparation (50 pg of protein) was incubated at 0°C for 60 min in tubes 
containing either 25 pi of ANP (1 pM ) or Tris/BSA and 100 pi of ^^^I-rANP 
(7.8 pM-1 nM). Binding increased with increasing ligand concentration and 
the Scatchard transformation of the data is shown in Fig.20. From the plot a 
dissociation equilibrium constant (K j^ ) of 794 pM and receptor number
(Bmax) of 254 fmol/mg protein was calculated.
7.5 Specificity of binding
The specificity of the ANP binding sites for ANP-related and unrelated 
peptides was examined in competitive binding experiments. ANP 
nomenclature is based on the sequence of the prepropeptide starting at the end 
of the signal peptide (Oikawa et al., 1984); thus a h-ANP (99-126)= human 
ANP (28 amino acid ), rANP fragment (111-126)= rat atrial peptide fragment 
(13-28), ANP fragment (99-109)= rat atrial peptide fragment (1-11). As 
shown (Fig.21), unrelated peptides such as angiotensin II, 
arginine-8-vasopressin and bradykinin did not compete for the ANP-binding 
sites. Of the ANP-related peptides which competed for the receptor, the 
following order of affinity was established; rat atrial peptide fragment 13-28 
> rANP (99-126) > hANP > rat atrial peptide fragment 8-33 > rat atrial 
peptide fragment 1-11 >atriopeptin I,
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Fig.l9: HPLC profile of pure i^^I-ANP (99-126), and
supernatant after incubation of (99-126) with
membrane for Ih at 0*^ C, 22®C and 37°C.
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Fig.20. Scatchard plot.
Scatchard analysis of specific binding of ^^^I-ANP (99-126) to membrane 
preparation as function of tracer concentration up to 2 nM. Points are mean 
of 3 separate experiments each performed in triplicate. Non-specific filter 
binding estimated throughout the range of tracer concentrations used 
amounted to less than 1 % of total counts.
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Fig.21: Competition for ANP (99-126) binding sites by ANP 
related and unrelated peptides.
i^^I-ANP (99-126) (200pM) was incubated with membrane for Ih at 0°C in 
the presence of increasing concentrations of the appropriate peptide. Apart 
from r-ANP (99-126) which shows the mean of 9 seperate experiments, 
each plot represent the mean of two experiments carried out in triplicate.
Hill coefficients for ANP and its competitors were calculated as follows; 
rANP (99-126) 0.21; fragment (1-11) 0.21; fragment (13-28) 0.18; fragment 
(8-33) 0.36; hANP 0.13. Shallow competitive binding curves have 
previously been observed in ANP receptor binding studies (Lyall et aL, 
1987) the significance of this is unclear.
6.6 Comparison with other studies
Many reports have been published which show that binding of ANP to its 
receptors on a number of target cells results in increasing levels of the second 
messenger cGMP ( section 4.5 ).
Previous studies have shown that ANP specific binding sites are present in 
rat adrenal capsules revealing aK ^of 0.1 nM (Schiffrin ef a/., 1985). Since 
this work was completed, Rathinavelu and Isom, (1988) have characterized 
specific receptors for ANP in rat PC 12 cells with a of 670 pM and 
receptor density of 29 femtomole/10^ ceUs.
The (0.794 nM) obtained from the present studies with rat PC12 cells
confirms that the receptor expressed in this cell line resembles closely that 
found in PC 12 cells by Rathinavelu and Isom, (1988), and in the intact 
adrenal gland.
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8. Binding studies with angiotensin II: Effect of nerve growth 
factor
Angiotensin II is an vasoactive hormone known to elevate blood pressure. 
Specific receptors for A II have been identified in the adrenal gland. These 
receptors were reported to be concentrated in the zona glomerulosa ( Douglas 
et al., 1978). Specific binding sites for A II also have been identified in a 
number of other target tissues ( McQueen, 1986 ).
Van Calker et at., (1987) have reported that rat PC12 cells preincubated with 
^H-inositol responded to stimulation by bradykinin, A II and carbachol with 
an increased formation of labeled inositol phosphates. It was thus of interest 
to find out whether or not this response was mediated by A H receptors and 
indeed if this clone of PC 12 cells expressed A II receptors. To investigate 
this possibility PC12 membranes (50 pg/lOO pi ) were prepared as described 
previously for ANP binding experiments. Competitive binding studies were 
performed again as described in section 7.5 in the presence of A II ranging 
from (IQ-^M—IQ-^^M ). Competitive binding experiments were chosen for 
preliminary experiments because they used less i^I-A n  (125 pM), which is 
expensive. When these experiments were carried out no specific binding of A 
II to the membrane preparation could be detected. Interestingly, the amount 
of non-specific binding of II to the membrane preparation was much 
less than that observed using i^^I-ANP. This is in agreement with results 
found by Morton, (1988) using membrane preparations derived from rat 
vascular smooth muscle ( personal communication ).
It was possible that these PC 12 cells might have lost their receptors over an 
unknown number of passages. To test this possibilty an experiment was 
designed to try to make the cells re-express the receptors. Cells were treated
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daily with NGF at a final concentration of 50ng/ml and ImM dibutyryl cAMP 
for 6 days. Since NGF is known to differentiate PC12 cells to become 
neuronal-like (section 3.1) it was possible that this might restore the A II 
receptors. When NGF and cAMP were added to PC 12 cells, they stopped 
dividing, extended neurites and generally became neuronal-like (Plate 1). A 
plasma membrane preparation was prepared from nerve growth factor-treated 
PC 12 cells as described in section 6.3-1 Plasma membrane preparations 
from non-treated cells were prepared as a control.
Although PC12 cells regained their original phenotype, they did not 
re-express angiotensin II receptors. It can be concluded therefore that NGF 
differentiates PC 12 cells but it does not cause re-expression of AII receptors.
4 4
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Plate 1. Normal PC 12 cells grown on collagen coated flasks (top 
photograph) and PC 12 cells on collagen coated flasks then treated with NGF 
(final concentration 50 ng/ml ) and cAMP (final concentration ImM ) daily for 
6 days (bottom photograph).
9. Characterization o f catecholamines released by PC12 cells
Greene and Tischler, (1976) have reported that PC 12 cells synthesize and 
store noradrenaline and dopamine. Rebois et aL, (1980) and Schubert and 
Klier, (1977) have also reported that PC12 cells store and secrete dopamine 
and acetylcholine. It was of interest therefore to identify which 
catecholamines were released by this PC 12 cell line. Six flasks (25 cm^) of 
confluent PC12 cells were exposed to 2 ml of 5 or 70mM K+ solution for 0, 
5 or 30 min. In the presence of 5mM K+ dopamine concentrations released 
into the medium after 0, 5 and 30 min were 44, 101.5 and 120 nM 
respectively, however in the presence of 70mM K+ dopamine released after 
0, 5 and 30 min was 90, 425 and 460 nM respectively (Fig. 22 ). Adrenaline 
and noradrenaline levels were too low (> 0.1 nM ) to be detected using this 
radio-enzymatic assay.
9.1 ^H-dopamine release from PC12 cells
The final event in stimulus-exocytosis coupling is the fusion of secretory 
vesicles with the plasma membrane. To investigate this event cells were 
permeabilized using different procedures for different cells. Kongsamut and 
Miller, (1986) studied the release of noradrenaline from normal PC12 cells 
and PC 12 cells treated with NGF in order to see if NGF treatment of PCI2 
cells altered the drug sensitivity of neurotransmitter release. PCI 2 cells 
became insensitive to dihydropyridines after their differentiation. One of the 
techniques used for looking at dopamine release from PC12 cells is to 
incubate them with ^H-dopamine. The ^H-dopamine is taken up across the 
plasma membrane into vesicles until released by various agonists. Melega 
and Howard, (1984) have showed that 2-(4-phenyl piperidino) cyclohexanol 
(AH 5183) at 40 pM had slight inhibitory effect on the loading of
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Fig.22: Release of dopamine from PC 12 cells.
PC12 cells were exposed to 5mM K+ (top graph) and 70mM K+ (bottom 
graph ) for 0, 5 and 30min respectively. Only dopamine was detectable in this 
radio-enzymatic assay. The points represent the mean of 2 experiments! SE.
3H-dopamine into vesicles. Ahnert-Hilger and Gratzl, (1987) have used 
a-toxin from Staphylococus aureus to permeabilize PC12 cells after loading 
them with ^H-dopamine.
Since it had been established in the previous experiments that PC 12 cells 
secrete dopamine, cells were loaded with ^H-dopamine and the effects of 
high potassium or ANP on ^H-dopamine release from the cells was 
investigated. Fig.23 illustrates the release of ^ H-dopamine from PC 12 cells 
after various stimuli. Cells were loaded with ^H-dopamine and then exposed 
to various potassium concentrations as described in section 6.5.
Three separate experiments were set up and cells were exposed to 3 different 
concentrations of potassium (5, 37 or 70mM K+ ). When the cells were 
exposed to 5mM K+ the release of ^ H-dopamine in the first 5 min was 6.4 % 
of total ^H-dopamine taken up by the cells and then remained at -3.06 % 
/5min for the remaining 25 min. The higher level of ^ H-dopamine released in 
the first 5min was probably due to free ^H-dopamine which had not been 
washed from the flasks after the loading and washing steps. The exposure to 
5mM K+ was considered as basal release (control). In the second set of 
experiments cells were exposed to 5mM K+ for the first 10 min , 37mM K+ 
for the second 10 min (Fig.23) and 5mM K+ again for the last 10 min. The 
release of dopamine when cells were exposed to 37mM K+ ( 15.8 % over 
10 min) was higher than that released by 5mM K+ but once the 37mM K+ 
solution was removed and replaced by 5mM K the release returned to normal 
(basal release). In the third set of experiments when the 37mM K+ solution 
was replaced by 70mM K+ solution, which depolarizes PC 12 cells, even
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Fig.23. ^H-dopamine release from PC 12 cells.
Cells were incubated with ^H-dopamine for 2h at 37°C, washed to 
remove the excess label and then exposed to different concentrations of 
potassium (5, 37 or 70mM K+). Points represent the mean of 2 
experiments each performed in triplicate ± SE.
** differs from * p < 0 .001 .
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higher levels (19 % ) of ^ H-dopamine was released over 10 minutes. It can 
be concluded that this PCI2 cell line secretes only dopamine and secretion of 
dopamine is elevated when the cells are depolarized using 70mM K+.
9.2 The effect of ANP on ^H-dopamine release from PC12 
cells.
Since this study has shown that ANP receptors are present on PC12 cells 
and that these same cells secrete dopamine, the question remained, did 
ANP have any direct effect on dopamine release ?
To test this possibility ANP ( final concentration lO'^M) was added to either 
the 5mM K+ or 70mM K+ solutions. Cells were then perfused with these 
two solutions (composition as in section 6.8-5—6 .8-6 ). ANP had no 
statistically significant effect on the release of dopamine from cells (Fig.24 
and 25).
9.3 ANP secretion
It is now well established that ANP is located within and secreted from the 
heart of many species. ANP is stored as 126 amino acid precursor (proANP) 
and cleaved upon its release to the circulating form (3000) (Thibault et al., 
1987). Studies on isolated perfused heart in vivo and in vitro has suggested 
that the atrial distension is a common physiological stimulus for ANP 
secretion (Thibault et al., 1987).
Recently Ong et al., (1987) demonstrated the co-existence of ANP (99-126) 
and its precursor ANP (1-126) within bovine chromaffin granules, 
comfirming the maturation process of atrial peptides in the adrenal medulla. 
Nguyen et al., (1988) have demonstrated that nicotinic activation (lOpM) and 
depolarization by KCI (56mM) increased secretion of ANP and its precursors 
from cultured chromaffin cells. In this study PC12 cells, derived from a
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Fig.24.The effect of ANP on dopamine release from PC12 cells.
Release of ^ H-dopamine from PC12 cells exposed to 5mM K ( top graph ) or 
5mM K solution containing lO-^M ANP ( bottom graph ). Points are the mean 
of 3 experiments each performed in triplicate ±SE. None of the lower bars 
differed significantly (p< 0.05) from the corresponding control value.
(Student t test ).
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Fig.25. The effect of ANP on ^H-dopamine release from PC12 
cells depolarized by 70mM K+.
Release of dopamine from PC 12 cells exposed to 70mM K+ solution (a) or 
70mM K+ containing ANP at final concentration of lO-^M (b). ANP was also 
added to the 5mM K+ solution. Points are the mean of 11 separate 
experiments ±SE. None of the lower bars differed significantlty (p<0.05) 
from the corresponding control value. (Students t test ).
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tumour of these chromaffin cells, were used to look for ANP secretion. The 
results obtained from the perfusion system when cells were exposed to 5mM 
K+ for 30 min are shown in Fig.26. These experiments show that ANP is 
present in the cells, but when cells were perfused with 70mM K+ (Fig.27) 
the response of cells in releasing ANP was clear after the removal of the 
70mM K+ and replacement by 5mM K+. Both set of experiments have 
indicate that ANP is present within PC12 cells. In a separate experiment, 
where six (25cm^) confluent flasks of PC 12 cells were exposed to 5mM K+, 
70mM K+ and 70mM K+ containing protease inhibitors at 37°C for 5 min 
(Fig.28). ANP released to the media was below the resolution of the assay (> 
5 pg/ml). The results, as can be seen, are not reproducible. To clarify this 
uncertainity requires further investigation. In a third set of experiments, 
where the supernatant of cells (homogenized) was assayed for ANP 
secretion, 420 pg/ml was detected in non-trypsinized cells and 248 pg/ml in 
trypsinized cells. Although PCI2 cells were not exposed to trypsin for longer 
than 5-6 min, trypsin does seem to affect the content of ANP in PC12 cells.
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Fig.26. The release of ANP from PC12 cells exposed to 5mM K+.
In a perfusion system PCI2 cells were exposed to 5mM K+ for 30 min. 2 ml 
samples were collected at 5 min intervals and assayed for ANP release (Fig. 14). 
3 individual experiments are shown in this Fig. and the bottom graph is the 
mean of all 3 ± SE.
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Fig.27. The release of ANP from depolarised PC12 cells .
In a perfusion system PC 12 cells were exposed to 5mM K+ for the first 10 min 
and then depolarised with 70mM K+ for 10 min. 5mM K+ replaced the 70mM 
K+ for the last 10 min. 2 ml samples were collected at 5 min intervals and 
assayed for ANP release (Fig. 14). 3 individual experiments are shown in this 
Fig. and the fourth is the mean of the 3 ± SE.
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Fig.28. The release of ANP from PC 12 cells.
6 confluent flasks (25cm^) received either 5mM K+. 70mM K+ or 70mM K+ 
containing protease inhibitors. The ANP released was below the normal range 
of plasma ANP concentration (5-50pg/ml). Points are one experiment each 
carried out in duplicate.
10. The measurement of renin in PC 12 cells
As described in section 6.7 patients with phaeochromocytoma are reported to 
have increased plasma renin activity. To investigate the possibility that PCI2 
cells secrete renin the following experiments were carried out. 10 (ISOcm^) 
collagen coated confluent flasks were prepared. Cells from five flasks were 
isolated by trypsinization. However trypsin is known to activate renin. Cells 
from five flasks were scraped from the flasks. Cells from each preparation 
were homogenized in 2 ml (Tris/HCl lOOmM) in a polytron homogenizer and 
spun for Ih at 40000 rpm at 5°C. The supernatant was removed and frozen 
until the assays were carried out.
The results from the radio-immunoassay were obtained after the incubation of 
samples (supernatant of lysed PC 12 cells ) with angiotensin I antiserum and 
rat renin substrate (see methods) for 0 and 5h at 0°C and at 37°C. At 0^ ’C , 
where renin would not be active, angiotensin I was undetectable in both the 
trypsinized and non-trypsinized PCI2 cells. After incubation for 5h at 37°C, 
angiotensin I generated was 37 pg/h for non-trypsinized cells and 42 pg/h for 
the trypsinized cells (roughly 150x10^ cells).
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Discussion
11. Discussion
General
The atrial natriuretic family of peptides isolated from the heart of mammalian 
and non-mammalian species, has been shown to possess powerful 
vasorelaxant and natriuretic activity (Garcia et aL, 1984). Since the 
discovery of these bioactive peptides (De Bold et aL, 1981), a great deal of 
interest has been generated in them. In that time the atrial natriuretic peptide 
has been purified, (Thibault et al., 1983) sequenced (Seidah et al, 1984) 
and the cDNA sequence of its precursor determined (Maki et aL, 1984).
The heart is an endocrine gland (Cantin and Genest, 1987) and releases the 
atrial natriuretic family of peptides into the bloodstream. This method of 
release allows these peptides to act at a wide range of target organs. ANP 
receptors have been identified in many organs involved in regulation of 
blood pressure and fluid and electrolyte homeostasis.
Phaeochromocytoma are tumours of chromaffin cells of the adrenal gland. 
PCI2 cells share many characteristics with normal chromaffin cells (section 
3.2) but once PC 12 cells are treated with NGF, they cease dividing and 
extend neurites to become neuronal-like cells ( Greene and Tischler, 1976). 
The ability of these PC 12 cells to take on neuronal properties has made these 
cells a useful model system for physiological studies; in particular, for 
studying the differentiation of neuroblasts into neurons and also to investigate 
the role and mechanisms of action of NGF on its target cells (Dichter et aL, 
1977). The cGMP response in PC12 cells to ANP may provide important 
clues concerning the molecular mechanisms of action of ANP in the central 
and peripheral nervous systems (Fiscus et aL, 1987).
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11.1 Binding studies with ANP
The present study demonstrates the presence of specific receptors for ANP in 
PC 12 cells, a cell line derived from a tumour of chromaffin cells in the rat
adrenal medulla. Binding studies revealed a of 794pM and a receptor
density (Bmax) of 256 fmol/mg of protein. The peptides related to ANP 
compete for the binding sites in the following order of affinities: rat atrial 
peptide fragment 13-28 aa > r-ANP (28 aa) > h-ANP (28 aa) > r-ANP (8-33 
aa ) rat atrial peptide fragment (1-1 laa) > atriopeptin I.
The data obtained from these binding studies was published in October 
1988. In the same month a paper was published by Rathinavelu and Isom, 
(1988) which contained data that was in close agreement with the present 
study. They characterized specific receptors for ANP in intact PC 12 cells. 
Their binding studies, using rat ANP (8-33), revealed a of 670pM and
receptor density of 29 femtomole/10^ cells. In their study, intact PC 12 cells 
(5x 10  ^cells/tube ) were incubated in suspension with i^^I-ANP (0.2-2nM) 
in the binding medium (RPMI medium containing 0.2 % BSA ) in a total 
volume of 200 |il at 0°C for 2h, All assays were performed with cells in 
suspension in polystyrene tubes. Separation of bound from free radioligand 
was obtained by filtration through GF/C glass fibre filters treated with 0.02% 
Tween 20 in PBS for 2h. Filters were washed with 10 ml of ice cold 0.15 M 
NaCl and then counted in a gamma counter. Although this method used
intact cells to characterize ANP receptors in PC 12 cells, the calculated 
from this method was still very similar to the found in the present study 
using membrane preparations. Rathinavelu and Isom, (1988) showed that 
ANP receptors were internalized by PC 12 cells when cells were incubated
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with 125i_a n P at 37°C. They demonstrated internalization of receptors as 
follows: at the end of the incubation period, tubes were placed on ice and 0.5 
M NaCl, 0.2M acetic acid was used to extract ANP bound to the cell surface. 
The internalized ligand, represented by the radioactivity remained in the cells, 
was determined by solubilizing the cells in IN NaOH (Rathinavelu and Isom,
1988). This work on intact cells which was published at the same time and is 
in close agreement with the present study, further suggests a regulatory role 
for ANP in the adrenal gland.
Both of these studies confirm the prediction of Fiscus et aL, (1987), that 
these cells would express high levels of ANP receptors since they have 
shown that ANP is coupled to cGMP accumulation in PC 12 cells. This 
project demonstrates the presence of specific ANP binding sites, on PC 12 
cells. The accumulation of cGMP in C6-2B rat glioma cells and in 
phaeochromocytoma PC 12 cells was stimulated by ANP related peptides in 
the following order of affinity ( Fiscus et aL, 1987) AP III = APII > h-ANP 
> AP I and this order of affinity of h-ANP and AP I is in agreement with the 
order of receptor affinity found in the present study. This data is also 
consistent with the idea that the biological response of ANP is via cell 
surface receptors since Fiscus et aL, (1987) have shown that atriopeptin II 
(lOOnM) activates particulate forms (membrane-associated) of the enzyme 
guanylate cyclase responsible for cGMP synthesis, rather than the soluble 
form. This isoenzyme form of guanylate cyclase binds ANP not only in 
PC 12 membrane preparations but also in several rat tissues. Furthermore, 
this group have shown that the ANP receptor coupled to cGMP synthesis in 
rat lung is a glycoprotein that copurifies with particulate guanylate cyclase 
(Kuno et aL, 1986). Chinkers et aL, (1989) have reported the isolation, 
sequence and expression of a complementary DNA clone encoding the
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membrane form of guanylate cyclase from rat brain. This cDNA was 
transfected into cultured mammalian cells and resulted in expression of 
guanylate cyclase activity and ANP-binding activity. This ANP 
receptor/guanylate cyclase represents a new class of mammalian cell-surface 
receptors which contain an extracellular ligand-binding domain and an 
intracellular guanylate cyclase catalytic domain. Cyclic GMP accumulation by 
atriopeptin II (23 aa ) was enhanced in the presence of the phosphodiesterase 
inhibitor 3-isobutyl-l-methylxanthine (IBMX) (250pM) with both C6-2B and 
PC 12 cells. This observation that addition of the phosphodiesterase inhibitor 
IBMX enhanced intracellular cGMP levels further suggests that ANP directly 
activates guanylate cyclase (Fiscus et aL, 1987).
Specific receptors for ANP have been identified in cultured N4TG1 
neuroblastoma cells . These cells have a single class of receptors for ANP
with a Kfj of IxlQ-i® M (Pandy et aL, 1987). ANP also stimulated cGMP
accumulation ( : lOOnM ) in these neuronal cells (Pandy et aL, 1987).
The calculated from Pandy's binding study agrees closely with the
value (794 pM) obtained from the present study on PC 12 cells. The
discrepancy of the K j^s of the ANP receptor and the stimulation of
intracellular cGMP by ANP in a number of cell types (Hirata et aL, 1984) has 
not yet been explained. The presence of ANP receptors in three neuronally 
derived cell lines, the N4TG1 neuroblastoma (mouse), C6-2B rat glioma 
cells and phaeochromocytoma PC 12 cells further supports the idea that ANP 
has an important function in the central and peripheral nervous system acting 
through its second messenger cGMP. Furthermore Schiffrin et aL, (1985)
have identified specific binding sites for ANP ( of 0.1 nM ) in a membrane
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fraction isolated from rat adrenal capsules. The value obtained from PC 12
cells confirms that the receptor expressed in this cell line closely resembles 
that found in the intact adrenal gland.
Initially, binding experiments were performed on cells attached to plastic 
tissue culture. However, during the incubation both at 0°C and 22°C the 
cells detached from the dishes. Because of the rapid breakdown of the 
1251-ANP at 37°C experiments on intact cells were not carried out at this 
temperature. At 37°C there was also the possibility that the ligand-receptor 
complex would become internalized by the cells. Since performing these 
experiments it has become clear that using collagen coated dishes might have 
overcome this problem by stopping the cells detaching at lower temperatures 
for the duration of the experiment and it would be of interest to go back and 
do further binding experiments on intact cells plated on collagen coated 
dishes. In a second attempt to characterize the ANP receptor on intact 
cells, PC 12 ceUs were used in suspension. For these experiments cells were 
grown on flasks and when confluent the flasks were left at 22°C for 5-10 
min. The cells could then be gently shaken from the flasks without enzyme 
treatment which could possibly have destroyed surface receptors. This 
method allowed binding experiments to be performed on cells in suspension 
at 0°C where breakdown of the ligand would be minimized. However, when 
the samples were filtered, they rapidly (0.45 |im Whatman filters) blocked 
the filters, thus preventing separation of bound and free ligand. At a later 
date, while performing the perfusion experiments, it became clear that glass 
fibre (GF/C) filters would have been much more suitable in the binding 
studies with cells in suspension. Because of the reasons outlined above 
binding studies were performed on membrane preparations at 0°C.
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11,2 Degradation of 1^®I-ANP
The temperature used in ANP binding experiments by other investigators 
usually varied between 0-37 °C. Most investigators do not appear to have 
performed HPLC on the ANP to check the breakdown of the label after 
incubation with the membrane preparation or cells .
Lyall et al., (1988), have shown that, after the incubation of ^^^I-ANP for 
Ih at 0°C with a membrane preparation from the human astrocytoma cell 
line clone D 384. 63 % of the ligand remained intact. By adding the protease 
inhibitors 0.5mmol phenylmethane sulphonyl fluoride/1, 0.1% (w/v) 
bacitracin and lumol aprotoninA ( PMSF) , they found that up to 85% of 
i25i-iabelled ANP remained intact. These inhibitors, however, adversely 
affected binding of the ligand to the membrane. Because the complete 
elimination of tracer degradation was not obtained in the presence of these 
inhibitors and because of adverse effects on ligand binding they chose to 
perform their experiments at 0°C for Ih without them. Schiffrin et aL, (1985) 
have examined the degradation of the ^^^I-ANP in mesenteric and adrenal 
membranes. The incubation of ^^^I-ANP with mesenteric or adrenal 
membranes in the presence of proteinase inhibitors (bacitracin, PMSF and 
aprotinin) resulted in more than 90 % of the labelled ANP remaining intact 
as shown by HPLC. Adrenal membranes were incubated with ^^^j.anP and 
then centrifuged, the label in the supernatant was removed and used in another 
binding experiment with a fresh membrane preparation, 92 % of this label 
was found to bind to these membranes on re-incubation . This result was in 
agreement with the results obtained from their HPLC experiments (Schiffrin 
et aL, 1985).
In the present study about 70 % of the labelled ANP remained intact in the
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presence of the membrane after incubation for Ih at 0°C. The percentage of 
intact label fell to 14 % and 3.6 % when the incubation was at 22°C and 
37°C respectively. Breakdown of the ligand could affect both the accuracy of 
the estimated k^ i value of the binding sites and also the number of binding
sites if the receptors themselves were damaged at 37°C.
11.3 Specificity of binding
The specificity of the binding sites for ANP related and unrelated peptides 
was examined in competitive binding experiments as shown in Fig.20. In 
this study, hormones unrelated to ANP, such as A II, bradykinin and 
arginine-8-vasopressin, did not compete for the binding sites. ANP-related 
peptides which compete for the binding sites were in the following order of 
affinity : Rat atrial peptide fragment (13-28 ) > r-ANP ( 28 aa ) > h-ANP ( 28 
aa ) >r-ANP (8-33 aa ) rat atrial peptide fragment (1-1 laa ) > atriopeptin I. 
This clearly shows the specificity of these binding sites for ANP. It is worth 
pointining out that peptides without disulphide bridges, like ANP fragment 
(1-11), did not compete in ANP binding studies using rat mesenteric artery 
membrane preparations (Lyall and Morton, 1987). Schiffrin et aL, (1985) 
have examined the displacement of labelled ANP (0.05 nM) in mensenteric 
and adrenal membranes (0.5 mg/ml) in a competitive binding study with 
unrelated peptides such as AII and vasopressin (AVP) (10’^  to lO'^M). The 
related peptides displaced i^^I-ANP in the following order of affinity. ANP 
(101-126) > ANP (101-125) > ANP (101-123) > ANP (102-126). 
Hormones unrelated to ANP, such as A II and AYP, did not compete for 
the binding sites.
Affinity cross-linking studies were performed by Rathinavelu and Isom, 
(1988) using i^^I-ANP and PC12 ceUs. Two labelled protein components of
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the PC 12 cell plasma membrane which bound the ^^^I-ANP migrated at 
molecular weight of 70000 and 130000 on SDS polyacrylamide gels. The 
same authors have shown that i^^I-ANP was bound to a single class of high 
affinity binding sites in PC12 cells thus suggesting that these PCI2 cells 
might possess two classes of receptors, one of which is linked to the 
particulate form of guanylate cyclase.
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12. Angiotensin II binding studies
ANP relaxes vascular smooth muscle cells by stimulating the synthesis of 
cGMP ( Atlas et aL, 1986; Winquist, 1986) and antagonizing the 
vasoconstrictor effects of other hormones such as AII. ANP also inhibits A 
II actions on other cell types such as the adrenal cells, for example ANP 
decreases A II evoked secretion and steroidogenesis in adrenal glomerulosa 
cells ( Elliot et aL, 1986). Feldberg and Lewis, (1964) have reported that 
angiotensin is a potent releaser of the medullary hormones, mainly 
adrenaline, from the adrenal gland.
Smith and Lincoln, (1987) have shown that the angiotensin II and other 
calcium-mobilizing stimuli markedly inhibited the accumulation of cGMP that 
is evoked by ANP in cultured smooth muscle cells. ANP inhibits the 
contractile effects of a variety of other hormones beside angiotensin II 
(Kleinert et aL, 1984). The antagonistic effect of these two hormones (ANP 
and A II) has been known for a long time. Since this study has shown that 
functional receptors for ANP are located on PCI2 cells it was of interest to 
investigate whether or not these PC12 cells have receptors for A II. 
Competitive binding studies were performed with i^^I-A II as described 
previously for ANP binding experiments. When these experiments were 
performed no specific binding of i^I-A II to the membrane preparation could 
be detected. In addition the amount of non-specific binding of ^^ I^-A II to 
the membrane preparation was much less than that observed using 
125i„anP and this finding is in agreement with the results found by Morton 
using a membrane preparation derived from rat vascular smooth muscle 
(personal communication).
Many investigators have added nerve growth factor to PC 12 cells to cause 
them to differentiate into neuronal-like cells, for a number of different
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studies. An experiment was designed in which PC 12 cells were treated daily 
with NGF at a final concentration of 50ng/ml and ImM dibutyryl cAMP for 6 
days in order to try to restore the A n  receptors. Although the differentiation 
of PC 12 cells was achieved when binding studies with II were carried 
out, these cells still did not express AII receptors.
It would have been interesting to look at ANP binding sites with 
differentiated PC 12 cells to see whether or not the same receptors for ANP 
would be expressed when cells are differentiated. Since the radiolabelled 
ANP is expensive this experiment was not performed. Recently Drewett et 
aL, (1988) have reported that ANP (101-126) inhibited the release of 
carbachol-induced noradrenaline release from differentiated PC 12 cells. This 
further proves that undifferentiated PC 12 cells express ANP binding sites 
and that differentiated PC 12 cells probably express them too.
Van Calker et aL, (1987) have found that bradykinin, A II and carbachol 
accumulated inositol phosphates in PC 12 cells and this was increased by 
adding lOmM lithium. To produce such an effect, it would have been 
expected that PC 12 cells expressed AII receptors. However, the PC12 cells 
used in this project did not appear to express any receptors for A II, Thus 
PC 12 cells either do not have surface receptors for A II or only certain clones 
of PC 12 cells express receptors for A II. Interestingly, it has been shown 
by a number of investigators that A II may be internalized and have 
intracellular effects. For example it has been reported that rat liver and 
spleen nuclei have specific nuclear binding sites for angiotensin II (Re et aL, 
1981). Autoradiographic studies have shown that ^H-A II was localized in 
the nucleus of smooth muscle cells ( Robertson and Khairallah, 1971). This 
finding has suggested that AII or its metabolic fragments have specific effects 
on nuclear function.
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The discrepancy between the results of A II binding studies in this project 
and the results showing A n  mediated IP3 production suggest the possibility 
that A II may be internalized with its receptors and may have some 
intracellular effect in PC 12 cells. It would be of interest to incubate PC 12 
cells with A II and use the techniques described by Rathinavelu and Isom, 
(1988) to show whether AII is internalized. If so, autoradiography could be 
performed to check where the AII was located.
If autoradiographic studies showed that A II was located on the nucleus 
then it would be of interest to perform i^^I-A II binding studies on nuclear 
membrane preparations from these cells. Furthermore since ANP has been 
shown to be internalized by PC12 cells (Rathinavelu and Isom, 1988) this 
suggests that ANP may have some intracellular effect on these cells, and it 
would be interesting to perform ANP-binding studies on nuclear membrane 
preparations from these cells.
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13. ^H-dopamine release from PC 12 cells
PC 12 cells synthesize, store and release noradrenaline and dopamine at higher 
rates than normal chromaffin cells (Greene and Tischler, 1976), however, 
the normal adrenal medulla synthesizes, stores and releases adrenaline, 
noradrenaline and dopamine. Recently Drewett et aL, (1988) have shown that 
carbachol-induced PC 12 cells derived from rat adrenal phaeochromocytoma 
released noradrenaline. Noradrenaline was assayed by HPLC with 
electrochemical detection. Many other investigators have shown that PC 12 
cells secrete noradrenaline, while some others have shown that PC 12 cells 
secrete dopamine (section 6.4). It was thus of interest to find out which 
catecholamines were released by the PCI2 cells used in this study.
Radio-immunoassay revealed that only dopamine was detectable in medium 
derived from these PC12 cells. The dopamine released was 44, 101.5 and 
120 nM after 0, 5 or 30 min in the presence of 5mM K+. In the presence of 
70mM K+ dopamine detected was 90, 425 and 460 nM after 0, 5 or 30 min. 
Adrenaline and noradrenaline were undetectable ( < 0.1 nM).
The next part of this work was to study the conditions under which 
dopamine was released. The catecholamine assay is a sensitive but 
time-consuming technique. Another approach to this work is to pre-load cells 
with ^H-dopamine and then quantify release of the radiolabel, following 
exposure to various potassium concentrations, using a scintillation counter. 
In the first set of experiments when PC 12 cells were exposed to 5mM K+ 
solution the ^H-dopamine released in the first 5 min was 6.4 % and then 
remained at -3.06 % for the remaining 25 min. This release was considered 
as basal (control). In the second set of experiments PC 12 cells were exposed 
to 5mM K+ for the first lOmin, where the release was at almost the same
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level as the previous set of experiments, and then exposed to 37mM K+ for 
the second 10 min, where the release was 15.8 % over lOmin, Once the 
37mM K+ was removed and replaced by 5mM K+ for the last 10 min the 
release returned to normal (basal release). The third set of experiments were 
performed in the same way as the previous experiments except 70mM K+ 
replaced the 37mM K+ solution. The release in the first lOmin was much the 
same as the basal release, however, the release after the exposure to 70noM 
K+ was 19 % over 10 min. This response of the PC 12 cell line to 
depolarization conditions further shows that these cells are a useful model for 
looking at signal-response coupling in neuronal cells.
13.1 The effect of ANP on the release of ^H-dopamine release 
from PC12 cells
Since PC 12 cells express binding sites for ANP and secrete dopamine, it was 
of interest to see whether ANP had any effect on dopamine release from these 
cells. In this study ANP had no statistically significant effect on inhibition of 
potassium-stimulated release of dopamine from PC 12 cells. Takagi et al., 
(1988) have shown that ANP (10"^ M) did not inhibit the K+ induced 
increase in Ca+"  ^influx rate from rat adrenal glomerulosa cells.
The normal adrenal medulla modulates blood pressure by releasing 
catecholamine hormones (adrenaline, noradrenaline and dopamine) into the 
bloodstream. These hormones help maintain normal blood volume and 
pressure. ANP and other vasorelaxant peptides may modulate blood pressure 
by acting through their specific receptors found on adrenal cells to inhibit the 
release of catecholamines which in turn relaxes smooth muscle.
ANP has been reported to inhibit adrenergic neurotransmission from 
presynaptic terminals in rat mesenteric arteries (Nakamura and Inagami,
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1986). Very recently Drewett et aL, (1988) have reported a pre-synaptic 
neuromodulatory effect of ANP on PC 12 cells. It has already been shown 
that differentiated PC 12 cells synthesize and accumulate noradrenaline and 
also release it when treated with the nicotinic agonist carbachol (Greene and 
Rein, 1977; Koike and Takashima, 1986). Drewett et aL, (1988) further 
showed that ANP (101-126) significantly inhibited carbachol-induced 
noradrenaline release in a concentration-dependent manner. Half maximal 
inhibition was produced at an ANP concentration of O.lnM. This study 
suggests that, at least with differentiated PC 12 cells, ANP is an inhibitory 
neuromodulator.
In a different study, Nakamura and Inagami, (1986) showed that ANP 
(lOOnM) only reduced electrically-induced ^H-noradrenaline release by 12% 
from PC 12 cells, whereas in the above paper lOOnM ANP resulted in total 
inhibition of carbachol-induced noradrenaline release.
In this project, ANP effects on neurotransmitter release were only 
performed on undifferentiated PC 12 cells. It would be of interest to 
differentiate these cells and see whether: a) The catecholamines produced by 
the cells are the same and b) Whether ANP had any effect on dopamine 
release. It is worth noting that the experiments in this study involved 
electrical stimulation with KCl rather than nicotinic agonists.
13.2 ANP secretion
Recently Ong et aL, (1987) demonstrated the co-existence of ANP (99-126) 
and its precursor ANP (1-126) within bovine chromaffin granules, 
comfirming the maturation process of atrial peptides in the adrenal medulla. 
Nguyen et aL, (1988) have demonstrated that nicotinic activation (10|jM) and 
depolarization by KCl (56mM) increased secretion of ANP and its precursors 
from cultured chromaffin cells. Because of these observations, it was of
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interest to see whether ANP could be detected in the PCI2 cells.
As discussed in section 6 .6 , three different methods were used to 
investigate this. In the first set of experiments cells were perfused with either 
5mM K+ or 70mM K+. The results ( 9.3 ) showed that PC12 cells do appear 
to release ANP into the medium but that depolarizing conditions did not have 
a reproducible effect on this release. In the second experiment, PC12 cells 
were exposed to either 5 or 70mM K+ in flasks (25 cm^). Although there 
were almost double the number of cells on the flasks, ANP was not detectable 
using this method. However, in the third experiment, the supernatant from 
homogenized cells (supernatant prepared for renin experiments) was assayed 
for ANP. The results were for trypsinized cells 248 pg/ml and for 
non-trypsinized cells (scraped from the flasks) 420 pg/ml. 1ml represented 
the ANP obtained from 75x10^ cells. Although the trypsin was external and 
the cells were not exposed to it for long time, it still affected internal ANP 
content. This experiment showed that ANP is present within the cells. The 
presence and release of ANP from PC 12 cells suggest a very important role 
played by this hormone, in normal adrenal cells, possibly through its 
specific receptors, (autocrine signaling ) which in turn regulates blood 
pressure.
The conclusion that could be drawn from these experiments is that PC 12 
cells contain intracellular ANP but it was not released under the conditions 
studied in these experiments. Further experiments are required to confirm 
whether or not it is indeed ANP (that is being released), or whether the 
antibody is cross-reacting with similar peptide. This could be investigated by 
performing HPLC on the samples ( Richards et ai, 1987 ).
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14. Measurement of intracellular renin in PC12 cells
Ganten et aL, (1974) reported the presence of renin-like activity in rat adrenal 
glands. In latter studies, investigators localized adrenal renin to the zona 
glomerulosa (Naruse etaL, 1984). Nakamaru et aL, (1985) have suggested 
that adrenal renin is involved in the regulation of aldosterone production. 
The interrelationship of catecholamines and renin angiotensin-aldosterone 
system (Peach, 1971) has been established by many investigators. 
Phaeochromocytoma are catecholmine-secreting tumours. They were found 
to be associated, in patients, with increased plasma renin activities (PRA) 
and aldosterone levels (Vetter et aL, 1975). The present study has shown the 
presence of renin within rat phaeochromocytoma PCI2 cells . This adds 
further support to the findings reported by Vetter et aL, (1975) that 
phaeochromocytoma cells secrete renin and therefore raises the possibility that 
these cells may be a useful model system for looking at renin release. At 0°C 
renin in the supernatant obtained from homogenized PCI2 cells [(roughly 150 
X 1Q6) homogenized in 2 ml of Tris lOOmM pH 7.4] was not detectable; 
however after incubation of the samples of this supernatant for 5h at 37°C, 
the renin detected was for trypsinized cells, 42 pg/h of A I, and for 
non-trypsinized cells, 37 pg/h of A I. There was not much difference 
between the results obtained from trypsinized and non-trypsinized cells, but 
still it can be said that trypsin contributed to the activation of renin even 
though PC12 cells were exposed to trypsin only for 5-6 min untü they started 
detaching.
Human nephroblastoma cells were reported by Inglis and Leckie, (in press
1989) to secrete renin and prorenin over 18 days in culture. Renin secreting 
cell cultures (human transfected juxtaglomerular cells ) have been described 
by Pinet et aL, (1987). Therefore, PC12 cells being a cultured tumour cell
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line and secreting renin, share these characteristics with human transfected 
juxtaglomerular cells (culture) and nephroblastoma (tumour).
PC 12 cells are known to release catecholamines into the bloodstream 
elevating blood pressure. The elevation of blood pressure stimulates the 
release of ANP from the heart, which in turn reduces blood pressure by 
relaxing smooth muscle cells. Also the renin-angiotensin system plays a 
major role in regulating blood pressure.
The presence of these three main blood pressure control elements 
(catecholamines, ANP and the renin -angiotensin system ) within PCI2 cells, 
tumours derived from normal adrenal chromaffin cells, shows clearly that 
these PC 12 cells could be an excellent model system for investigating 
biosynthesis, maturation and secretion of atrial peptides (Nguyen et aL, 
1988), as well as for the physiological role of the co-secretion of 
neuropeptides and catecholamines in the nervous system (differentiated PC 12 
cells).
In conclusion, PC 12 cells represent an extremely useful model system in 
investigating many aspects of blood pressure regulation.
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